THE LUBRIZOL CORPORATION 10-Q
UNITED
STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
|
|
|
þ |
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the quarterly period ended June 30, 2005
OR
|
|
|
o |
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the transition period from ___to ___
Commission File Number 1-5263
THE LUBRIZOL CORPORATION
(Exact name of registrant as specified in its charter)
|
|
|
Ohio
|
|
34-0367600 |
(State or other jurisdiction of
|
|
(I.R.S.Employer |
incorporation or organization)
|
|
Identification No.) |
29400 Lakeland Boulevard
Wickliffe, Ohio 44092-2298
(Address of principal executive offices)
(Zip Code)
(440) 943-4200
(Registrants telephone number, including area code)
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by
Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for
such shorter period that the registrant was required to file such reports), and (2) has been
subject to such filing requirements for the past 90 days.
Yes þ No o
Indicate by check mark whether the registrant is an accelerated filer (as defined in Rule 12b-2 of
the Exchange Act). Yes þ No o
Number of the registrants common shares, without par value, outstanding as of July 31, 2005:
67,885,976
THE LUBRIZOL CORPORATION
Quarterly Report on Form 10-Q
Quarter Ended June 30, 2005
Table of Contents
-2-
PART I. FINANCIAL INFORMATION
Item 1. Financial Statements
THE LUBRIZOL CORPORATION
CONSOLIDATED STATEMENTS OF INCOME
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months |
|
|
Six Months |
|
|
|
Ended June 30, |
|
|
Ended June 30, |
|
(in millions except per share data) |
|
2005 |
|
|
2004 |
|
|
2005 |
|
|
2004 |
|
|
Net sales |
|
$ |
1,066.0 |
|
|
$ |
720.2 |
|
|
$ |
2,036.1 |
|
|
$ |
1,298.1 |
|
Royalties and other revenues |
|
|
0.6 |
|
|
|
1.3 |
|
|
|
1.6 |
|
|
|
2.1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total revenues |
|
|
1,066.6 |
|
|
|
721.5 |
|
|
|
2,037.7 |
|
|
|
1,300.2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cost of sales |
|
|
795.1 |
|
|
|
529.5 |
|
|
|
1,512.2 |
|
|
|
955.8 |
|
Selling and administrative expenses |
|
|
94.3 |
|
|
|
70.2 |
|
|
|
187.3 |
|
|
|
122.0 |
|
Research, testing and development expenses |
|
|
50.9 |
|
|
|
45.5 |
|
|
|
101.4 |
|
|
|
86.3 |
|
Amortization of intangible assets |
|
|
6.1 |
|
|
|
4.5 |
|
|
|
12.7 |
|
|
|
6.4 |
|
Write-off of acquired in-process
research and development |
|
|
|
|
|
|
35.0 |
|
|
|
|
|
|
|
35.0 |
|
Restructuring charges |
|
|
5.4 |
|
|
|
8.0 |
|
|
|
11.5 |
|
|
|
8.0 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total costs and expenses |
|
|
951.8 |
|
|
|
692.7 |
|
|
|
1,825.1 |
|
|
|
1,213.5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other income (expense) net |
|
|
0.7 |
|
|
|
(1.9 |
) |
|
|
1.4 |
|
|
|
2.4 |
|
Interest income |
|
|
1.9 |
|
|
|
1.0 |
|
|
|
3.7 |
|
|
|
1.9 |
|
Interest expense |
|
|
(26.8 |
) |
|
|
(18.1 |
) |
|
|
(53.1 |
) |
|
|
(24.3 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Income before income taxes |
|
|
90.6 |
|
|
|
9.8 |
|
|
|
164.6 |
|
|
|
66.7 |
|
Provision for income taxes |
|
|
30.5 |
|
|
|
5.9 |
|
|
|
56.0 |
|
|
|
25.2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income |
|
$ |
60.1 |
|
|
$ |
3.9 |
|
|
$ |
108.6 |
|
|
$ |
41.5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income per share, basic |
|
$ |
0.88 |
|
|
$ |
0.08 |
|
|
$ |
1.60 |
|
|
$ |
0.80 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income per share, diluted |
|
$ |
0.87 |
|
|
$ |
0.08 |
|
|
$ |
1.59 |
|
|
$ |
0.80 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Dividends per share |
|
$ |
0.26 |
|
|
$ |
0.26 |
|
|
$ |
0.52 |
|
|
$ |
0.52 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted-average common shares outstanding |
|
|
68.0 |
|
|
|
51.9 |
|
|
|
67.7 |
|
|
|
51.8 |
|
Amounts shown are unaudited.
See accompanying notes to the financial statements.
-3-
THE LUBRIZOL CORPORATION
CONSOLIDATED BALANCE SHEETS
|
|
|
|
|
|
|
|
|
|
|
June 30, |
|
|
December 31, |
|
(in millions except per share data) |
|
2005 |
|
|
2004 |
|
|
ASSETS |
|
|
|
|
|
|
|
|
Cash and short-term investments |
|
$ |
279.0 |
|
|
$ |
335.9 |
|
Receivables net |
|
|
641.1 |
|
|
|
582.8 |
|
Inventories |
|
|
559.1 |
|
|
|
568.7 |
|
Other current assets |
|
|
106.8 |
|
|
|
110.6 |
|
|
|
|
|
|
|
|
Total current assets |
|
|
1,586.0 |
|
|
|
1,598.0 |
|
|
|
|
|
|
|
|
Property and equipment at cost |
|
|
2,596.0 |
|
|
|
2,731.3 |
|
Less accumulated depreciation |
|
|
1,391.9 |
|
|
|
1,413.4 |
|
|
|
|
|
|
|
|
Property and equipment net |
|
|
1,204.1 |
|
|
|
1,317.9 |
|
|
|
|
|
|
|
|
Goodwill |
|
|
1,147.9 |
|
|
|
1,153.8 |
|
Intangible assets net |
|
|
419.3 |
|
|
|
437.1 |
|
Investments in non-consolidated companies |
|
|
7.3 |
|
|
|
7.4 |
|
Other assets |
|
|
48.4 |
|
|
|
52.1 |
|
|
|
|
|
|
|
|
TOTAL |
|
$ |
4,413.0 |
|
|
$ |
4,566.3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
LIABILITIES AND SHAREHOLDERS EQUITY |
|
|
|
|
|
|
|
|
Short-term debt and current portion of long-term debt |
|
$ |
4.3 |
|
|
$ |
8.2 |
|
Accounts payable |
|
|
302.9 |
|
|
|
339.6 |
|
Accrued expenses and other current liabilities |
|
|
299.9 |
|
|
|
309.5 |
|
|
|
|
|
|
|
|
Total current liabilities |
|
|
607.1 |
|
|
|
657.3 |
|
|
|
|
|
|
|
|
Long-term debt |
|
|
1,836.5 |
|
|
|
1,964.1 |
|
Postretirement health-care obligations |
|
|
106.5 |
|
|
|
106.4 |
|
Noncurrent liabilities |
|
|
185.1 |
|
|
|
170.7 |
|
Deferred income taxes |
|
|
75.5 |
|
|
|
90.7 |
|
|
|
|
|
|
|
|
Total liabilities |
|
|
2,810.7 |
|
|
|
2,989.2 |
|
|
|
|
|
|
|
|
|
Minority interest in consolidated companies |
|
|
52.3 |
|
|
|
53.6 |
|
Contingencies and commitments |
|
|
|
|
|
|
|
|
Shareholders equity: |
|
|
|
|
|
|
|
|
Preferred stock without par value authorized
and unissued: |
|
|
|
|
|
|
|
|
Serial preferred stock 2,000,000 shares |
|
|
|
|
|
|
|
|
Serial preference shares 25,000,000 shares |
|
|
|
|
|
|
|
|
Common shares without par value: |
|
|
|
|
|
|
|
|
Authorized 120,000,000 shares
Outstanding - 67,819,761 shares as of June 30, 2005
after deducting 18,376,133 treasury shares,
66,778,865 shares as of December 31, 2004
after deducting 19,417,029 treasury shares |
|
|
651.6 |
|
|
|
610.6 |
|
Retained earnings |
|
|
988.4 |
|
|
|
897.4 |
|
Accumulated other comprehensive (loss) income |
|
|
(90.0 |
) |
|
|
15.5 |
|
|
|
|
|
|
|
|
Total shareholders equity |
|
|
1,550.0 |
|
|
|
1,523.5 |
|
|
|
|
|
|
|
|
TOTAL |
|
$ |
4,413.0 |
|
|
$ |
4,566.3 |
|
|
|
|
|
|
|
|
Amounts shown are unaudited.
See accompanying notes to the financial statements.
-4-
THE LUBRIZOL CORPORATION
CONSOLIDATED STATEMENTS OF CASH FLOWS
|
|
|
|
|
|
|
|
|
|
|
Six Months |
|
|
|
Ended June 30, |
|
(in millions of dollars) |
|
2005 |
|
|
2004 |
|
|
Cash provided by (used for): |
|
|
|
|
|
|
|
|
Operating activities: |
|
|
|
|
|
|
|
|
Net income |
|
$ |
108.6 |
|
|
$ |
41.5 |
|
Adjustments to reconcile net income to cash provided
by operating activities: |
|
|
|
|
|
|
|
|
Depreciation and amortization |
|
|
91.7 |
|
|
|
60.9 |
|
Write-off of acquired in-process research and development |
|
|
|
|
|
|
35.0 |
|
Deferred income taxes |
|
|
3.9 |
|
|
|
1.2 |
|
Restructuring charges |
|
|
5.1 |
|
|
|
1.6 |
|
Change in current assets and liabilities, net of acquisitions: |
|
|
|
|
|
|
|
|
Receivables |
|
|
(88.0 |
) |
|
|
(77.0 |
) |
Inventories |
|
|
(8.4 |
) |
|
|
(1.8 |
) |
Accounts payable, accrued expenses and other current liabilities |
|
|
(3.5 |
) |
|
|
19.9 |
|
Other current assets |
|
|
7.4 |
|
|
|
(2.1 |
) |
Other items net |
|
|
23.8 |
|
|
|
17.0 |
|
|
|
|
|
|
|
|
Total operating activities |
|
|
140.6 |
|
|
|
96.2 |
|
Investing activities: |
|
|
|
|
|
|
|
|
Capital expenditures |
|
|
(58.6 |
) |
|
|
(42.2 |
) |
Acquisitions net of cash received and liabilities assumed |
|
|
|
|
|
|
(960.7 |
) |
Other items net |
|
|
3.2 |
|
|
|
|
|
|
|
|
|
|
|
|
Total investing activities |
|
|
(55.4 |
) |
|
|
(1,002.9 |
) |
Financing activities: |
|
|
|
|
|
|
|
|
Changes in short-term debt net |
|
|
(3.7 |
) |
|
|
1,800.1 |
|
Repayments of long-term debt |
|
|
(125.0 |
) |
|
|
(934.9 |
) |
Long-term borrowings |
|
|
|
|
|
|
25.0 |
|
Dividends paid |
|
|
(35.0 |
) |
|
|
(26.8 |
) |
Proceeds from the exercise of stock options |
|
|
37.4 |
|
|
|
5.5 |
|
|
|
|
|
|
|
|
Total financing activities |
|
|
(126.3 |
) |
|
|
868.9 |
|
Effect of exchange rate changes on cash |
|
|
(15.8 |
) |
|
|
6.4 |
|
|
|
|
|
|
|
|
Net decrease in cash and short-term
investments |
|
|
(56.9 |
) |
|
|
(31.4 |
) |
Cash and short-term investments at beginning of period |
|
|
335.9 |
|
|
|
258.7 |
|
|
|
|
|
|
|
|
Cash and short-term investments at end of period |
|
$ |
279.0 |
|
|
$ |
227.3 |
|
|
|
|
|
|
|
|
Amounts shown are unaudited.
See accompanying notes to the financial statements.
-5-
THE LUBRIZOL CORPORATION
Notes to Consolidated Financial Statements
June 30, 2005
1. Basis of Presentation
The accompanying unaudited consolidated financial statements have been prepared in accordance with
generally accepted accounting principles for interim financial information and Article 10 of
Regulation S-X. Accordingly, they do not include all of the information and footnotes required by
generally accepted accounting principles for complete financial statements. In the opinion of
management, all adjustments (consisting of normal recurring accruals unless otherwise noted)
considered necessary for a fair presentation have been included. Operating results for the three
and six months ended June 30, 2005 are not necessarily indicative of the results that may be
expected for the year ending December 31, 2005.
The balance sheet at December 31, 2004 has been derived from the audited financial statements at
that date but does not include all of the information and footnotes required by accounting
principles generally accepted in the United States for complete financial statements.
2. Significant Accounting Policies
Net Income Per Share
Net income per share is computed by dividing net income by the weighted-average common shares
outstanding during the period, including contingently issuable shares. Net income per diluted
share includes the dilutive effect resulting from outstanding stock options and stock awards. Per
share amounts are computed as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months |
|
|
Six Months |
|
|
|
Ended June 30, |
|
|
Ended June 30, |
|
(in millions except per share data) |
|
2005 |
|
|
2004 |
|
|
2005 |
|
|
2004 |
|
Numerator: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income |
|
$ |
60.1 |
|
|
$ |
3.9 |
|
|
$ |
108.6 |
|
|
$ |
41.5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Denominator: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted-average common shares
outstanding |
|
|
68.0 |
|
|
|
51.9 |
|
|
|
67.7 |
|
|
|
51.8 |
|
Dilutive effect of stock options and
awards |
|
|
0.7 |
|
|
|
0.3 |
|
|
|
0.8 |
|
|
|
0.3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Denominator for net income per share,
diluted |
|
|
68.7 |
|
|
|
52.2 |
|
|
|
68.5 |
|
|
|
52.1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income per share, basic |
|
$ |
0.88 |
|
|
$ |
0.08 |
|
|
$ |
1.60 |
|
|
$ |
0.80 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income per share, diluted |
|
$ |
0.87 |
|
|
$ |
0.08 |
|
|
$ |
1.59 |
|
|
$ |
0.80 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted-average shares issuable upon the exercise of stock options that were excluded from the
diluted earnings per share calculations because they were antidilutive for the three and six months
ended June 30, 2004 were 1.7 million and 1.8 million, respectively.
Stock-Based Compensation
The company has elected the intrinsic value method to account for stock-based employee
compensation. The following table shows the pro forma effect on net income per share if the
company had applied the fair value recognition provisions of the Financial Accounting Standards
Boards (FASB) Statement of Financial Accounting Standard (SFAS) No. 123, Accounting for
Stock-Based Compensation, to stock-based employee compensation.
-6-
THE LUBRIZOL CORPORATION
Notes to Consolidated Financial Statements
June 30, 2005
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months |
|
|
Six Months |
|
|
|
Ended June 30, |
|
|
Ended June 30, |
|
(in millions of dollars except per share data) |
|
2005 |
|
|
2004 |
|
|
2005 |
|
|
2004 |
|
Reported net income |
|
$ |
60.1 |
|
|
$ |
3.9 |
|
|
$ |
108.6 |
|
|
$ |
41.5 |
|
Plus: stock-based employee compensation (net
of tax) included in net income |
|
|
1.4 |
|
|
|
0.8 |
|
|
|
2.8 |
|
|
|
0.9 |
|
Less: stock-based employee compensation (net
of tax) using the fair value method |
|
|
(1.3 |
) |
|
|
(1.6 |
) |
|
|
(3.5 |
) |
|
|
(2.6 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Pro forma net income |
|
$ |
60.2 |
|
|
$ |
3.1 |
|
|
$ |
107.9 |
|
|
$ |
39.8 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Reported net income per share, basic |
|
$ |
0.88 |
|
|
$ |
0.08 |
|
|
$ |
1.60 |
|
|
$ |
0.80 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Pro forma net income per share, basic |
|
$ |
0.88 |
|
|
$ |
0.06 |
|
|
$ |
1.59 |
|
|
$ |
0.77 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Reported net income per share, diluted |
|
$ |
0.87 |
|
|
$ |
0.08 |
|
|
$ |
1.59 |
|
|
$ |
0.80 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Pro forma net income per share, diluted |
|
$ |
0.87 |
|
|
$ |
0.06 |
|
|
$ |
1.58 |
|
|
$ |
0.77 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
New Accounting Standards
In June 2005, the FASB issued SFAS No. 154, Accounting Changes and Error Corrections. This
standard establishes new standards on accounting for changes in accounting principles. Pursuant to
the new rules, all such changes must be accounted for by retrospective application to the financial
statements of prior periods unless it is impracticable to do so. SFAS No. 154 completely replaces
Accounting Principles Board (APB) Opinion No. 20 and SFAS No. 3, though it carries forward the
guidance in those pronouncements with respect to accounting for changes in estimates, changes in
the reporting entity and the correction of errors. The company does not believe the adoption of
this standard will have a material impact on its financial position, results of operations or cash
flows.
In March 2005, the FASB issued Interpretation (FIN) No. 47, Accounting for Conditional
Asset-Retirement Obligations. This standard codifies SFAS No. 143, Asset-Retirement
Obligations, and states that companies must recognize a liability for the fair value of a legal
obligation to perform asset-retirement obligations that are conditional on a future event if the
amount can be reasonably estimated. Specifically, FIN No. 47 provides additional guidance on
whether the fair value is reasonably estimable. FIN No. 47 is effective for the company starting
January 1, 2006. The company does not believe the adoption of this standard will have a material
impact on its financial position, results of operations or cash flows.
In December 2004, the FASB issued SFAS No. 123(R), Share-Based Payment. This standard will
require compensation costs related to share-based payment transactions to be recognized in the
financial statements. With limited exceptions, the amount of compensation cost will be measured
based on the grant-date fair value of the equity or liability instruments issued. In addition,
liability awards will be remeasured each reporting period. Compensation cost will be recognized
over the period that an employee provides service in exchange for the award. This standard
replaces SFAS No. 123 and supersedes APB Opinion No. 25, Accounting for Stock Issued to
Employees, and applies to all awards granted, modified, repurchased or cancelled after July 1,
2005. In April 2005, the Securities and Exchange Commission (SEC) amended the compliance date of
SFAS No. 123(R) through an amendment of Regulation S-X. The new effective date for the company is
January 1, 2006. The company currently is evaluating the provisions of this standard to determine
the impact on its consolidated financial statements. It is, however, expected to reduce
consolidated net income.
-7-
THE LUBRIZOL CORPORATION
Notes to Consolidated Financial Statements
June 30, 2005
In December 2004, the FASB issued SFAS No. 153, Exchanges of Nonmonetary Assets. This standard
amended APB Opinion No. 29, Accounting for Nonmonetary Transactions, to eliminate the exception
from fair-value measurement for nonmonetary exchanges of similar productive assets. This standard
replaces this exception with a general exception from fair-value measurement for exchanges of
nonmonetary assets that do not have commercial substance. A nonmonetary exchange has commercial
substance if the future cash flows of the entity are expected to change significantly as a result
of the exchange. This statement is effective for all nonmonetary asset exchanges completed by the
company starting January 1, 2006. The company does not believe the adoption of this standard will
have a material impact on its financial position, results of operations or cash flows.
In November 2004, the FASB issued SFAS No. 151, Inventory Costs, to clarify the accounting for
abnormal amounts of idle facility expense, freight, handling costs and wasted material. This
standard requires that such items be recognized as current-period charges. The standard also
establishes the concept of normal capacity and requires the allocation of fixed production
overhead to inventory based on the normal capacity of the production facilities. Any unallocated
overhead must be recognized as an expense in the period incurred. This standard is effective for
inventory costs incurred starting January 1, 2006. The company does not believe the adoption of
this standard will have a material impact on its financial position, results of operations or cash
flows.
Use of Estimates
The preparation of consolidated financial statements in conformity with accounting principles
generally accepted in the United States of America requires management to make estimates and
assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent
assets and liabilities at the date of the financial statements and the reported amounts of revenues
and expenses during the reporting period. Actual results could differ from those estimates.
3. Acquisitions and Pro Forma Financial Information
On June 3, 2004, the company completed the acquisition of Noveon International, Inc. (Noveon
International) for cash of $920.2 million (inclusive of $32.9 million in certain seller expenses)
plus transaction costs of $11.4 million and less cash acquired of $103.0 million. In addition, the
company assumed $1,103.1 million of long-term indebtedness from Noveon International. With the
acquisition of Noveon International, the company has accelerated its program to attain a
substantial presence in the personal care and coatings markets by adding a number of higher-growth,
industry-leading products under highly recognizable brand names, including Carbopol®, to
the companys portfolio of lubricant and fuel additives and consumer products. Additionally,
Noveon International has a number of industry-leading specialty materials businesses, including
TempRite® chlorinated polyvinyl chloride and Estane® thermoplastic
polyurethane.
The acquisition and related costs were financed initially with the proceeds of a $2,450.0 million
364-day bridge credit facility. Shortly after the acquisition, the company repaid substantially
all of the assumed long-term debt of Noveon International with proceeds of the temporary bridge
loan. In addition, the temporary bridge loan was repaid in full in September 2004 with the
proceeds from the permanent financing obtained by the issuance of senior notes, debentures, bank
term loans and equity.
The consolidated balance sheets as of June 30, 2005 and December 31, 2004 reflect the acquisition
of Noveon International under the purchase method of accounting. The company recorded the various
assets acquired and liabilities assumed, primarily working capital accounts, of Noveon
International at their estimated fair values determined as of the acquisition date. Actuarial
valuations were completed for the projected pension and other post-employment benefit obligations
and were reflected in the purchase price allocation. Appraisals of long-lived assets and
identifiable intangible assets, including an evaluation of in-process research and development
(IPR&D) projects, were also obtained. Through June 2005, the company was still finalizing certain
aspects of the purchase price
-8-
THE LUBRIZOL CORPORATION
Notes to Consolidated Financial Statements
June 30, 2005
allocation primarily surrounding the valuation of the property, plant and equipment and the
deferred tax accounts. In connection with the acquisition of Noveon International, the company has
targeted non-core businesses with total revenues of approximately $500.0 million for disposition.
This plan was contemplated at the time of acquisition and plan activities have been underway since
the fourth quarter of 2004. In addition, through June 2005, the company was still in the process
of finalizing its reconciliation of the underlying fixed-asset records to the respective
appraisals. As a result of both of these efforts, in the six months ended June 30, 2005, the
company reduced the amount allocated to property, plant and equipment by $55.2 million since
December 31, 2004. Depreciation expense for the three and six months ended June 30, 2005 included
a related adjustment of $1.1 million and $2.3 million, respectively, representing the change in
depreciation expense associated with the change in the estimated fair values assigned to property,
plant and equipment. In addition, the deferred tax accounts were adjusted in June 2005 resulting
in a decrease of $17.7 million to the net deferred tax liabilities since December 31, 2004. The
goodwill associated with the transaction increased by $33.7 million in the six months ended June
30, 2005 representing the net impact of all adjustments recorded. The allocation of the purchase
price was complete as of June 30, 2005 and the related actuarial valuations and appraisals obtained
have been finalized.
The purchase price included the estimated fair value of IPR&D projects totaling $34.0 million that,
as of the acquisition date, had not yet reached technological feasibility and had no alternative
future use. As a result, the full amount allocated to IPR&D was expensed in 2004. The amount
charged to expense in the second quarter of 2004 was $35.0 million. This amount was subsequently
adjusted to $34.0 million in the second half of 2004. There have been no changes to the valuation
of IPR&D in 2005. The inventory step-up to fair value totaled $24.2 million, of which $4.9 million
was expensed in the second quarter of 2004. As the remaining step-up relates to inventories
accounted for on the LIFO method of accounting, the company does not anticipate that additional
amounts of step-up will be expensed in the near term.
The adjusted fair value of the assets acquired and liabilities assumed in connection with the
Noveon International acquisition was as follows as of June 30, 2005:
|
|
|
|
|
|
|
Fair Value of Net |
|
(in millions of dollars) |
|
Assets Acquired |
|
Receivables |
|
$ |
191.5 |
|
Inventories |
|
|
180.5 |
|
Other current assets |
|
|
47.4 |
|
Property and equipment |
|
|
559.6 |
|
Goodwill |
|
|
863.8 |
|
Intangible assets |
|
|
379.1 |
|
Other non-current assets |
|
|
18.2 |
|
|
|
|
|
Total assets |
|
|
2,240.1 |
|
|
|
|
|
|
|
|
|
|
Accounts payable |
|
|
129.4 |
|
Accrued expenses |
|
|
107.2 |
|
Current and long-term debt |
|
|
1,103.1 |
|
Noncurrent liabilities |
|
|
71.8 |
|
|
|
|
|
Total liabilities |
|
|
1,411.5 |
|
|
|
|
|
Increase in net assets from acquisition |
|
$ |
828.6 |
|
|
|
|
|
-9-
THE LUBRIZOL CORPORATION
Notes to Consolidated Financial Statements
June 30, 2005
The companys operating results for the three and six months ended June 30, 2004 only include
revenues and expenses of Noveon International since June 3, 2004, the date of acquisition.
The following unaudited pro forma operating data is presented for the three and six months ended
June 30, 2004 as if the Noveon International acquisition had been completed at the beginning of
each of the periods presented below in the table. The pro forma data gives effect to actual
operating results prior to the acquisition. Adjustments to cost of sales for the inventory step-up
charge, fixed asset depreciation, intangible asset amortization, the write-off of acquired IPR&D,
interest expense and income taxes related to the acquisition are reflected in the pro forma data.
In addition, the company assumed that the bridge loan obtained at the time of the transaction
closing was not replaced with the permanent long-term financing consisting of both debt and equity
until the end of the fourth month in the period presented. These pro forma amounts do not purport
to be indicative of the results that actually would have been obtained if the acquisition had
occurred as of the beginning of the periods presented or that may be obtained in the future.
|
|
|
|
|
|
|
|
|
|
|
Three Months |
|
|
Six Months |
|
|
|
Ended |
|
|
Ended |
|
(in millions of dollars except per share data) |
|
June 30, 2004 |
|
|
June 30, 2004 |
|
Total revenues |
|
$ |
939.0 |
|
|
$ |
1,837.8 |
|
|
|
|
|
|
|
|
Net income |
|
$ |
15.0 |
|
|
$ |
59.7 |
|
|
|
|
|
|
|
|
Net income per share, basic |
|
$ |
0.29 |
|
|
$ |
1.06 |
|
|
|
|
|
|
|
|
Net income per share, diluted |
|
$ |
0.29 |
|
|
$ |
1.05 |
|
|
|
|
|
|
|
|
On January 30, 2004, the company completed the acquisition of the coatings hyperdispersants
business of Avecia. This business is headquartered in Blackley, United Kingdom and develops,
manufactures and markets high-value additives that are based on polymeric dispersion technology and
used in coatings and inks. These products enrich and strengthen color while reducing production
costs and solvent emissions, and are marketed under the brand names Solsperse®,
Solplus® and Solthix®. Historical annual revenues of this business are
approximately $50.0 million. The 2004 historical results only include revenues and expenses of
hyperdispersants since the date of acquisition.
4. Inventory
The companys inventory was comprised of the following as of June 30, 2005 and December 31, 2004:
|
|
|
|
|
|
|
|
|
|
|
June 30, |
|
|
December 31, |
|
(in millions of dollars) |
|
2005 |
|
|
2004 |
|
Finished products |
|
$ |
305.9 |
|
|
$ |
311.2 |
|
Products in process |
|
|
86.6 |
|
|
|
75.9 |
|
Raw materials |
|
|
138.3 |
|
|
|
153.1 |
|
Supplies and engine test parts |
|
|
28.3 |
|
|
|
28.5 |
|
|
|
|
|
|
|
|
Total inventory |
|
$ |
559.1 |
|
|
$ |
568.7 |
|
|
|
|
|
|
|
|
5. Goodwill and Intangible Assets
The major components of the companys identifiable intangible assets are customer lists,
technology, trademarks, patents, land-use rights and non-compete agreements. Excluding the
non-amortized trademarks, which are indefinite-lived and will not be amortized, the intangible
assets are amortized over the lives of the respective agreements or other periods of value, which
range between three and forty years. We assess the indefinite-lived trademarks for impairment
separately from goodwill.
-10-
THE LUBRIZOL CORPORATION
Notes to Consolidated Financial Statements
June 30, 2005
The following table shows the components of the companys identifiable intangible assets as of June
30, 2005 and December 31, 2004:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
June 30, 2005 |
|
|
December 31, 2004 |
|
|
|
Gross |
|
|
|
|
|
|
Gross |
|
|
|
|
|
|
Carrying |
|
|
Accumulated |
|
|
Carrying |
|
|
Accumulated |
|
(in millions of dollars) |
|
Amount |
|
|
Amortization |
|
|
Amount |
|
|
Amortization |
|
Amortized intangible assets: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Customer lists |
|
$ |
153.2 |
|
|
$ |
11.3 |
|
|
$ |
151.9 |
|
|
$ |
6.4 |
|
Technology |
|
|
144.4 |
|
|
|
30.5 |
|
|
|
144.4 |
|
|
|
25.4 |
|
Trademarks |
|
|
24.5 |
|
|
|
3.3 |
|
|
|
24.4 |
|
|
|
2.3 |
|
Patents |
|
|
12.4 |
|
|
|
2.0 |
|
|
|
13.2 |
|
|
|
1.5 |
|
Land-use rights |
|
|
7.1 |
|
|
|
0.9 |
|
|
|
7.1 |
|
|
|
0.8 |
|
Non-compete agreements |
|
|
8.9 |
|
|
|
4.8 |
|
|
|
8.9 |
|
|
|
3.8 |
|
Other |
|
|
5.6 |
|
|
|
0.6 |
|
|
|
11.3 |
|
|
|
0.9 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total amortized
intangible assets |
|
|
356.1 |
|
|
|
53.4 |
|
|
|
361.2 |
|
|
|
41.1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Non-amortized trademarks |
|
|
116.6 |
|
|
|
|
|
|
|
117.0 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
472.7 |
|
|
$ |
53.4 |
|
|
$ |
478.2 |
|
|
$ |
41.1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Annual intangible amortization expense for the next five years will approximate $25.6 million for
2005, $25.4 million in 2006, $23.9 million in 2007, $22.4 million in 2008 and $20.6 million in
2009.
The carrying amount of goodwill by reporting segment as of June 30, 2005 is as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Lubricant |
|
|
Specialty |
|
|
|
|
(in millions of dollars) |
|
Additives |
|
|
Chemicals |
|
|
Total |
|
Balance, January 1, 2005 |
|
$ |
100.9 |
|
|
$ |
1,052.9 |
|
|
$ |
1,153.8 |
|
Goodwill adjustments |
|
|
|
|
|
|
33.7 |
|
|
|
33.7 |
|
Foreign currency
translation
adjustments |
|
|
(2.2 |
) |
|
|
(37.4 |
) |
|
|
(39.6 |
) |
|
|
|
|
|
|
|
|
|
|
Balance, June 30, 2005 |
|
$ |
98.7 |
|
|
$ |
1,049.2 |
|
|
$ |
1,147.9 |
|
|
|
|
|
|
|
|
|
|
|
The adjustment to goodwill recorded in 2005 relates to the Noveon International purchase
accounting.
Goodwill is tested for impairment at the reporting unit level annually as of October 1 of each year
or if events or circumstances occur that would more likely than not reduce the fair value of a
reporting unit below its carrying amount.
6. Comprehensive Income
Total comprehensive income for the three and six months ended June 30, 2005 and 2004 was comprised
of the following:
-11-
THE LUBRIZOL CORPORATION
Notes to Consolidated Financial Statements
June 30, 2005
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months |
|
|
Six Months |
|
|
|
Ended June 30, |
|
|
Ended June 30, |
|
(in millions of dollars) |
|
2005 |
|
|
2004 |
|
|
2005 |
|
|
2004 |
|
Net income |
|
$ |
60.1 |
|
|
$ |
3.9 |
|
|
$ |
108.6 |
|
|
$ |
41.5 |
|
Foreign currency translation adjustment |
|
|
(58.4 |
) |
|
|
(5.0 |
) |
|
|
(107.1 |
) |
|
|
(7.8 |
) |
Pension plan minimum liability |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
0.3 |
|
Unrealized gains (losses) - natural
gas hedges |
|
|
(0.5 |
) |
|
|
|
|
|
|
0.2 |
|
|
|
0.2 |
|
Unrealized gains - interest rate swaps |
|
|
|
|
|
|
1.7 |
|
|
|
|
|
|
|
2.1 |
|
Amortization of treasury rate locks |
|
|
0.8 |
|
|
|
(8.0 |
) |
|
|
1.4 |
|
|
|
(8.0 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total comprehensive income (loss) |
|
$ |
2.0 |
|
|
$ |
(7.4 |
) |
|
$ |
3.1 |
|
|
$ |
28.3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
7. Segment Reporting
The company is organized into two operating and reporting segments: Lubricant Additives and
Specialty Chemicals. The Lubricant Additives segment, also referred to as Lubrizol Additives,
represented 58% and 56% of the companys consolidated revenues for the three and six months ended
June 30, 2005, respectively, and is comprised of the companys businesses in fluid technologies for
transportation, advanced fluid systems, emulsified products and the industrial additives product
group. The Specialty Chemicals segment, also referred to as the Noveon segment, represented 42%
and 44% of the companys consolidated revenues for the three and six months ended June 30, 2005,
respectively, and is comprised of the businesses of the acquired Noveon International and the
former performance chemicals group of the company.
Lubricant Additives consists of three product lines: engine additives; specialty driveline and
industrial oil additives; and services and equipment. Engine additives is comprised of additives
for lubricating engine oils, such as for gasoline, diesel, marine and stationary gas engines and
additive components, and additives for fuel products and refinery and oil field chemicals. In
addition, this product line sells additive components and viscosity improvers within its lubricant
and fuel additives product areas. Specialty driveline and industrial oil additives is comprised of
additives for driveline oils, such as automatic transmission fluids, gear oils and tractor
lubricants and industrial oil additives, such as additives for hydraulic, grease and metalworking
fluids, as well as compressor lubricants. Services and equipment is comprised of fluid metering
devices, particulate emission trap devices, FluiPak® sensor systems and outsourcing
strategies for supply chain and knowledge center management. Lubricant Additives product lines are
produced generally in company-owned shared manufacturing facilities and sold largely to a common
customer base.
The Specialty Chemicals segment consists of consumer specialties, specialty materials and
performance coatings product lines. The consumer specialties product line is characterized by
global production of acrylic thickeners, specialty monomers, film formers, fixatives, emollients,
silicones, surfactants, botanicals, active pharmaceutical ingredients and intermediates, process
chemicals, benzoate preservatives, fragrances, defoamers, synthetic food and technical dyes, rubber
and lubricant antioxidants and rubber accelerators. The company markets products in the consumer
specialties product line to the following primary end-use industries: personal care,
pharmaceuticals, textiles, food and beverage, automotive and aerospace. The consumer specialties
products are sold to customers worldwide and these customers include major manufacturers of
cosmetics, personal care products, water soluble polymers, household products, soft drinks and food
products and major manufacturers in the automotive and aerospace industries. The specialty
materials product line is characterized by products such as chlorinated polyvinyl chloride (CPVC)
resins and compounds and is also a producer of thermoplastic polyurethane (TPU) and cross-linked
polyethylene compounds (PEX). The company markets products of specialty materials through the
primary product category of specialty plastics. Specialty materials products are sold to a diverse
customer base comprised of major
-12-
THE LUBRIZOL CORPORATION
Notes to Consolidated Financial Statements
June 30, 2005
manufacturers in the construction, automotive, telecommunications, electronics and recreation
industries. The performance coatings product line includes high-performance polymers for specialty
paper, printing and packaging, industrial and architectural specialty coatings and textile
applications. The company markets the performance coatings products through the primary product
categories of performance polymers and coatings and textile performance chemicals. Performance
coatings products serve major companies in the specialty paper, printing and packaging, paint and
coatings, and textile industries.
The company primarily evaluates performance and allocates resources based on segment operating
income, defined as revenues less expenses identifiable to the product lines included within each
segment, as well as projected future returns. Segment operating income will reconcile to
consolidated income before tax by deducting corporate expenses and corporate other income (expense)
that are not directly attributable to the operating segments, the write-off of acquired IPR&D,
restructuring charges and net interest expense.
The following table presents a summary of the results of the companys reportable segments for the
three and six months ended June 30, 2005 and 2004:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months |
|
|
Six Months |
|
|
|
Ended June 30, |
|
|
Ended June 30, |
|
(in millions of dollars) |
|
2005 |
|
|
2004 |
|
|
2005 |
|
|
2004 |
|
Revenues from external customers: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Lubricant Additives |
|
$ |
619.9 |
|
|
$ |
522.8 |
|
|
$ |
1,144.5 |
|
|
$ |
1,014.7 |
|
Specialty Chemicals |
|
|
446.7 |
|
|
|
198.7 |
|
|
|
893.2 |
|
|
|
285.5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total revenues |
|
$ |
1,066.6 |
|
|
$ |
721.5 |
|
|
$ |
2,037.7 |
|
|
$ |
1,300.2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Segment operating income: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Lubricant Additives |
|
$ |
85.2 |
|
|
$ |
72.8 |
|
|
$ |
154.0 |
|
|
$ |
135.5 |
|
Specialty Chemicals |
|
|
51.4 |
|
|
|
11.4 |
|
|
|
103.0 |
|
|
|
16.4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Segment operating income |
|
|
136.6 |
|
|
|
84.2 |
|
|
|
257.0 |
|
|
|
151.9 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Corporate expenses |
|
|
(15.8 |
) |
|
|
(12.3 |
) |
|
|
(30.8 |
) |
|
|
(21.6 |
) |
Corporate other income (expense) |
|
|
0.1 |
|
|
|
(2.0 |
) |
|
|
(0.7 |
) |
|
|
1.8 |
|
Write-off of acquired IPR&D |
|
|
|
|
|
|
(35.0 |
) |
|
|
|
|
|
|
(35.0 |
) |
Restructuring charges |
|
|
(5.4 |
) |
|
|
(8.0 |
) |
|
|
(11.5 |
) |
|
|
(8.0 |
) |
Interest expense net |
|
|
(24.9 |
) |
|
|
(17.1 |
) |
|
|
(49.4 |
) |
|
|
(22.4 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Income before income taxes |
|
$ |
90.6 |
|
|
$ |
9.8 |
|
|
$ |
164.6 |
|
|
$ |
66.7 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
-13-
THE LUBRIZOL CORPORATION
Notes to Consolidated Financial Statements
June 30, 2005
The companys total assets by segment were as follows:
|
|
|
|
|
|
|
|
|
|
|
June 30, |
|
|
December 31, |
|
(in millions of dollars) |
|
2005 |
|
|
2004 |
|
Segment total assets: |
|
|
|
|
|
|
|
|
Lubricant Additives |
|
$ |
1,223.8 |
|
|
$ |
1,337.1 |
|
Specialty Chemicals |
|
|
2,749.2 |
|
|
|
2,733.3 |
|
|
|
|
|
|
|
|
Total segment assets |
|
|
3,973.0 |
|
|
|
4,070.4 |
|
|
|
|
|
|
|
|
|
|
Corporate assets |
|
|
440.0 |
|
|
|
495.9 |
|
|
|
|
|
|
|
|
Total consolidated assets |
|
$ |
4,413.0 |
|
|
$ |
4,566.3 |
|
|
|
|
|
|
|
|
8. Pension and Postretirement Benefits
The components of net periodic pension cost and postretirement benefits costs consist of the
following:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months |
|
|
Six Months |
|
|
|
Ended June 30, |
|
|
Ended June 30, |
|
(in millions of dollars) |
|
2005 |
|
|
2004 |
|
|
2005 |
|
|
2004 |
|
Pension benefits: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Service cost - benefits earned
during period |
|
$ |
7.2 |
|
|
$ |
5.2 |
|
|
$ |
14.2 |
|
|
$ |
8.7 |
|
Interest cost on projected
benefit obligation |
|
|
8.1 |
|
|
|
8.1 |
|
|
|
15.9 |
|
|
|
12.9 |
|
Expected return on plan assets |
|
|
(6.7 |
) |
|
|
(7.9 |
) |
|
|
(13.5 |
) |
|
|
(13.2 |
) |
Amortization of prior service costs |
|
|
0.6 |
|
|
|
0.6 |
|
|
|
1.1 |
|
|
|
1.0 |
|
Amortization of initial net asset
obligation |
|
|
|
|
|
|
(0.2 |
) |
|
|
0.1 |
|
|
|
(0.4 |
) |
Recognized net actuarial loss |
|
|
1.5 |
|
|
|
1.5 |
|
|
|
2.7 |
|
|
|
1.8 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net periodic benefit cost |
|
$ |
10.7 |
|
|
$ |
7.3 |
|
|
$ |
20.5 |
|
|
$ |
10.8 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other benefits: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Service cost - benefits earned
during period |
|
$ |
0.2 |
|
|
$ |
0.7 |
|
|
$ |
0.9 |
|
|
$ |
1.3 |
|
Interest cost on projected
benefit obligation |
|
|
1.1 |
|
|
|
1.8 |
|
|
|
2.9 |
|
|
|
3.5 |
|
Amortization of prior service costs |
|
|
(2.2 |
) |
|
|
(1.5 |
) |
|
|
(3.8 |
) |
|
|
(3.1 |
) |
Recognized net actuarial loss |
|
|
0.4 |
|
|
|
0.6 |
|
|
|
1.0 |
|
|
|
1.3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net periodic benefit (income) cost |
|
$ |
(0.5 |
) |
|
$ |
1.6 |
|
|
$ |
1.0 |
|
|
$ |
3.0 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
-14-
THE LUBRIZOL CORPORATION
Notes to Consolidated Financial Statements
June 30, 2005
Expected employer contributions worldwide for pension benefits in 2005 approximate $31.9 million
for the qualified plans, of which $11.3 million was paid in the six months ended June 30, 2005.
The portion of the 2005 total expected contributions attributable to the U.S. qualified pension
plans is $17.7 million, of which $3.1 million was paid in the six months ended June 30, 2005. The
non-qualified pension plans and postretirement benefit plans are unfunded. As a result, the 2005
expected contributions to these plans of $2.1 million and $4.7 million, respectively, represent
actuarial estimates of future assumed payments based on historic retirement and payment patterns as
well as medical trend rates and historical claim information, as appropriate.
As part of the Noveon International integration efforts to provide consistent benefits, the company
communicated to employees in May 2005 changes to the benefits structure of certain of its U.S.
pension and postretirement benefit plans. This communication triggered a remeasurement of the
related benefit obligations and net periodic benefit cost in 2005 for both the legacy Noveon
International U.S. pension plans as well as for the U.S. postretirement benefit plan. As a result
of the second quarter remeasurement date, the discount rate for the legacy Noveon International
U.S. pension plans was reduced by 25 basis points to 5.75%. In addition, the discount rate for the
U.S. postretirement benefit plan was reduced by 50 basis points to 5.75%. The net impact of the
above changes reduced our aggregate net periodic pension and postretirement benefit cost by $0.9
million in the three and six months ended June 30, 2005. The annual savings projected for 2005 are
estimated at approximately $3.5 million and the annualized savings are estimated to be
approximately $5.3 million.
9. Restructuring Charges
In the three and six months ended June 30, 2005, the company recorded aggregate restructuring
charges of $5.4 million and $11.5 million, respectively, primarily related to the phase-out of
manufacturing facilities in both the Lubricant Additives and Specialty Chemicals segments as well
as other workforce reductions.
The following table shows the reconciliation of the restructuring liability since December 31, 2004
by major restructuring activity:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Liability |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Liability |
|
|
|
December 31, |
|
|
Restructuring |
|
|
|
|
|
|
Asset |
|
|
June 30, |
|
(in millions of dollars) |
|
2004 |
|
|
Charges |
|
|
Cash Paid |
|
|
Impairments |
|
|
2005 |
|
Performance coatings plant closures
and workforce reductions |
|
$ |
|
|
|
$ |
7.1 |
|
|
$ |
(1.0 |
) |
|
$ |
(4.4 |
) |
|
$ |
1.7 |
|
Bromborough, United Kingdom closure |
|
|
|
|
|
|
3.4 |
|
|
|
(0.6 |
) |
|
|
(0.7 |
) |
|
|
2.1 |
|
Corporate workforce reductions |
|
|
2.7 |
|
|
|
0.7 |
|
|
|
(2.7 |
) |
|
|
|
|
|
|
0.7 |
|
Noveon International restructuring
liabilities assumed |
|
|
6.1 |
|
|
|
0.3 |
|
|
|
(4.3 |
) |
|
|
|
|
|
|
2.1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
8.8 |
|
|
$ |
11.5 |
|
|
$ |
(8.6 |
) |
|
$ |
(5.1 |
) |
|
$ |
6.6 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
-15-
THE LUBRIZOL CORPORATION
Notes to Consolidated Financial Statements
June 30, 2005
In May 2005, the company announced the reorganization of the Specialty Chemicals performance
coatings product line. This product line includes businesses acquired from Noveon International as
well as businesses included in the companys legacy operations. In connection with the
reorganization, management eliminated 14 positions in North America and Europe. These reductions
were completed by June 30, 2005 and resulted in a severance-related charge of $1.1 million recorded
in the three and six months ended June 30, 2005.
In the first quarter of 2005, management made the decision and announced the future closure of two
Specialty Chemicals performance coatings production facilities in the United States. The aggregate
restructuring charge recorded for these closures for the three months ended June 30, 2005 was $1.1
million, comprised of $0.5 million in exit costs and $0.6 million in severance costs. The
aggregate restructuring charge recorded for these closures for the six months ended June 30, 2005
was $6.0 million, comprised of $4.4 million in asset impairments, $0.9 million in exit costs and
$0.7 million in severance costs. The company estimates it will incur cumulative severance costs of
approximately $2.1 million relating to these closures. An impairment charge for both plants was
recorded in the first quarter of 2005 to reflect the related assets at their estimated fair values.
The estimated fair value of the assets primarily was determined from third-party appraisals.
Production for these sites will be transferred to other facilities in the United States. The
facility in Mountaintop, Pennsylvania is scheduled to close in the third quarter of 2005. The
facility in Linden, New Jersey is scheduled to close in the second quarter of 2006. These closures
will result in a workforce reduction of 62 employees by the second quarter of 2006.
In December 2004, management made the decision to close the Lubricant Additives manufacturing
facility in Bromborough, United Kingdom. The company announced this decision in January 2005. The
company determined, as of December 31, 2004, that an impairment of certain of the facilitys
long-lived assets had been triggered by this decision in the fourth quarter of 2004. As a result,
a $17.0 million impairment charge was recorded in December 2004 to reflect the related assets at
their estimated fair values. The estimated fair value of the assets was determined using a
discounted cash flow model. Production phase-out of this site is planned to begin in the third
quarter of 2005 and is expected to be completed by late 2006. During this phase-out, United
Kingdom production will be transferred to facilities in France and the United States.
Approximately 69 employees will be impacted by this closure. The aggregate restructuring charge
recorded for this closure for the three months ended June 30, 2005 was $2.5 million, comprised of
$0.7 million in asset impairments, $0.3 million in exit costs and $1.5 million in severance costs.
The aggregate restructuring charge recorded for this closure for the six months ended June 30, 2005
was $3.4 million, comprised of $0.7 million in asset impairments, $0.5 million in exit costs and
$2.2 million in severance costs. The company currently anticipates that pre-tax charges for cash
expenditures of approximately $13.5 million to $15.5 million will be incurred in 2005 through 2007
to satisfy severance and retention obligations, plant dismantling, site restoration and other site
environmental evaluation costs and lease-related costs, including the $2.7 million recorded through
June 30, 2005.
In June 2004, the company eliminated more than 100 positions, primarily affecting technical and
commercial employees located at the Wickliffe, Ohio headquarters. Most of these workforce
reductions were related to the restructuring following the acquisition of Noveon International.
These reductions were completed by December 31, 2004. In the three months ended June 30, 2005, the
company began a process of identifying further opportunities to increase efficiency and
productivity, reduce costs and support the companys integration strategy of the Noveon
International acquisition. As a result, the company reduced headcount in the general and
administrative area of its headquarters offices in Ohio. Through these restructuring efforts, the
company eliminated seven positions resulting in a severance-related charge of $0.7 million. All of
the affected employees had left their positions by June 30, 2005 and the remaining
personnel-related costs are expected to be paid by 2006. The company continues to evaluate other
opportunities to integrate general and administrative functions. As such opportunities are
identified in future periods, the company expects further restructuring charges.
-16-
THE LUBRIZOL CORPORATION
Notes to Consolidated Financial Statements
June 30, 2005
The company assumed a restructuring liability of $7.2 million in 2004 relating to the legacy
operations of Noveon International. This liability was $6.1 million at December 31, 2004 and $2.1
million at June 30, 2005.
The charges for these cost reduction initiatives are reported as a separate line item in the
consolidated income statements, entitled Restructuring charges and are included in the Total
cost and expenses subtotal on the consolidated income statements.
10. Debt
On March 29, 2005, the company amended and restated its five-year unsecured bank credit agreement
to reduce the credit spread that is paid on the outstanding $500.0 million term loans. Based on
the companys current unsecured senior debt ratings from Standard and Poors and Moodys Investors
Services, the credit spread on the term loans was reduced by 50 basis points. No other terms or
conditions of the agreement were modified.
In the three months ended June 30, 2005, the company repaid $125.0 million against the bank term
loan. The balance outstanding at June 30, 2005 under the term-loan arrangement was $375.0 million.
In July 2005, the company repaid an additional $25.0 million against the bank term loan to reduce
the remaining outstanding balance to $350.0 million.
11. Shareholders Equity
The following table summarizes the changes in shareholders equity since December 31, 2004:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Shareholders Equity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accumulated |
|
|
|
|
|
|
Number of |
|
|
|
|
|
|
|
|
|
|
Other |
|
|
|
|
|
|
Shares |
|
|
Common |
|
|
Retained |
|
|
Comprehensive |
|
|
|
|
|
|
Outstanding |
|
|
Shares |
|
|
Earnings |
|
|
Income (Loss) |
|
|
Total |
|
(in millions) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance, January 1, 2005 |
|
|
66.8 |
|
|
$ |
610.6 |
|
|
$ |
897.4 |
|
|
$ |
15.5 |
|
|
$ |
1,523.5 |
|
Comprehensive income: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income |
|
|
|
|
|
|
|
|
|
|
108.6 |
|
|
|
|
|
|
|
108.6 |
|
Other comprehensive loss |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(105.5 |
) |
|
|
(105.5 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Comprehensive income |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3.1 |
|
Dividends declared |
|
|
|
|
|
|
|
|
|
|
(17.6 |
) |
|
|
|
|
|
|
(17.6 |
) |
Deferred stock compensation |
|
|
|
|
|
|
4.7 |
|
|
|
|
|
|
|
|
|
|
|
4.7 |
|
Common shares treasury: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Shares issued upon exercise
of stock options and awards |
|
|
1.0 |
|
|
|
36.3 |
|
|
|
|
|
|
|
|
|
|
|
36.3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance, June 30, 2005 |
|
|
67.8 |
|
|
$ |
651.6 |
|
|
|
988.4 |
|
|
$ |
(90.0 |
) |
|
$ |
1,550.0 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
12. Contingencies
The company has numerous purchase commitments for materials, supplies and energy in the ordinary
course of business. The company has numerous sales commitments for product supply contracts in the
ordinary course of business.
-17-
THE LUBRIZOL CORPORATION
Notes to Consolidated Financial Statements
June 30, 2005
General
On May 13, 2005, the company was named in a suit alleging patent infringement. The suit is pending
in federal court in Norfolk, Virginia and pertains to some of the companys additives for automatic
transmission fluids sold by the Lubricant Additives segment. The company is contesting the suit
vigorously and neither the company nor its counsel believes that an unfavorable outcome is
probable.
In addition, there are pending or threatened claims, lawsuits and administrative proceedings
against the company or its subsidiaries, all arising from the ordinary course of business with
respect to commercial, product liability and environmental matters, which seek remedies or damages.
The company believes that any liability that may finally be determined with respect to commercial
and product liability claims should not have a material adverse effect on the companys
consolidated financial position, results of operations or cash flows. From time to time, the
company is also involved in legal proceedings as a plaintiff involving contract, patent protection,
environmental and other matters. Gain contingencies, if any, are recognized when they are
realized.
Environmental
The companys environmental engineers and consultants review and monitor environmental issues at
operating facilities and, where appropriate, the company initiates corrective and/or preventive
environmental projects to ensure environmental compliance and safe and lawful activities at its
current operations. The company also conducts compliance and management systems audits.
The company and its subsidiaries are generators of both hazardous and non-hazardous wastes, the
treatment, storage, transportation and disposal of which are regulated by various laws and
governmental regulations. These laws and regulations generally impose liability for costs to
investigate and remediate contamination without regard to fault and, under certain circumstances,
liability may be joint and several resulting in one party being held responsible for the entire
obligation. Liability may also include damages to natural resources. Although the company
believes past operations were in substantial compliance with the then-applicable regulations,
either the company or the predecessor of Noveon International, the Performance Materials Segment of
Goodrich Corporation (Goodrich), has been designated under a countrys laws and/or regulations as a
potentially responsible party (PRP) in connection with several sites including both third party
sites and/or current operating facilities.
The company participates in the remediation process for onsite and third-party waste management
sites at which the company has been identified as a PRP. This process includes investigation,
remedial action selection and implementation, as well as discussions and negotiations with other
parties, which primarily include PRPs, past owners and operators and governmental agencies. The
estimates of environmental liabilities are based on the results of this process. Inherent
uncertainties exist in these estimates primarily due to unknown conditions, changing governmental
regulations and legal standards regarding liability, remediation standards and evolving
technologies for managing investigations and remediations. The company revises its estimates
accordingly as events in this process occur and additional information is obtained.
The companys environmental reserves, measured on an undiscounted basis, totaled $28.5 million at
June 30, 2005 and $26.4 million at December 31, 2004. Of these amounts, $4.1 million and $4.5
million were included in accrued expenses and other current liabilities at June 30, 2005 and
December 31, 2004, respectively. The companys June 30, 2005 balance sheet includes liabilities,
measured on an undiscounted basis, of $17.8 million to cover future environmental expenditures for
Noveon International sites either payable by Noveon International or indemnifiable by Goodrich.
Accordingly, the current portion of the Noveon International environmental obligations of $0.7
million is recorded in accrued expenses and other current liabilities and $0.4 million of the
recovery due from Goodrich is
-18-
THE LUBRIZOL CORPORATION
Notes to Consolidated Financial Statements
June 30, 2005
recorded in receivables. Non-current Noveon International liabilities include $17.1 million and
other assets include $2.6 million reflecting the recovery due from Goodrich.
Goodrich provided Noveon International with an indemnity for various environmental liabilities.
The company estimates Goodrichs share of such currently identified liabilities under the
indemnity, which extends through February 2011, to be approximately $3.0 million. There are
specific environmental contingencies for company-owned sites for which third parties such as past
owners and/or operators are the named PRPs and also for which the company is indemnified by
Goodrich. Goodrich is currently indemnifying Noveon International for several environmental
remediation projects. Goodrichs share of all of these liabilities may increase to the extent such
third parties fail to honor their obligations through February 2011.
The company believes that its environmental accruals are adequate based on currently available
information. The company believes that it is reasonably possible that $3.9 million in additional
costs may be incurred at certain locations beyond the amounts accrued as a result of new
information, newly discovered conditions, changes in remediation standards or technologies or a
change in the law. Additionally, as the indemnification from Goodrich extends through February
2011, changes in assumptions regarding when costs will be incurred may result in additional
expenses to the company. Additional costs in excess of $3.9 million cannot currently be estimated.
13. Guarantor and Non-Guarantor Subsidiary Information
The repayment of the unsecured senior notes, debentures and bank term loans is unconditionally
guaranteed on a joint and several basis by the company and its direct and indirect, wholly owned,
domestic subsidiaries. The following supplemental condensed consolidating financial information
presents the companys statements of income for the three and six months ended June 30, 2005 and
2004, its balance sheets as of June 30, 2005 and December 31, 2004 and its statements of cash flow
for the six months ended June 30, 2005 and 2004. The elimination of intercompany profit in
inventory as of the respective balance sheet date is reflected in the eliminations columns of the
condensed consolidating financial information.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Condensed Consolidating Statement of Income |
|
|
|
Three Months Ended June 30, 2005 |
|
|
|
Parent |
|
|
Subsidiary |
|
|
Other |
|
|
|
|
|
|
Total |
|
(in millions of dollars) |
|
Company |
|
|
Guarantors |
|
|
Subsidiaries |
|
|
Eliminations |
|
|
Consolidated |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net sales |
|
$ |
355.8 |
|
|
$ |
329.7 |
|
|
$ |
531.2 |
|
|
$ |
(150.7 |
) |
|
$ |
1,066.0 |
|
Royalties and other revenues |
|
|
0.5 |
|
|
|
0.1 |
|
|
|
|
|
|
|
|
|
|
|
0.6 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total revenues |
|
|
356.3 |
|
|
|
329.8 |
|
|
|
531.2 |
|
|
|
(150.7 |
) |
|
|
1,066.6 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cost of sales |
|
|
279.4 |
|
|
|
254.0 |
|
|
|
412.4 |
|
|
|
(150.7 |
) |
|
|
795.1 |
|
Selling and administrative expenses |
|
|
36.7 |
|
|
|
33.4 |
|
|
|
24.2 |
|
|
|
|
|
|
|
94.3 |
|
Research, testing and development
expenses |
|
|
22.8 |
|
|
|
10.3 |
|
|
|
17.8 |
|
|
|
|
|
|
|
50.9 |
|
Amortization of intangible assets |
|
|
0.8 |
|
|
|
4.1 |
|
|
|
1.2 |
|
|
|
|
|
|
|
6.1 |
|
Restructuring charges |
|
|
1.0 |
|
|
|
1.0 |
|
|
|
3.4 |
|
|
|
|
|
|
|
5.4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total costs and expenses |
|
|
340.7 |
|
|
|
302.8 |
|
|
|
459.0 |
|
|
|
(150.7 |
) |
|
|
951.8 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other income (expense) - net |
|
|
6.6 |
|
|
|
2.9 |
|
|
|
(7.4 |
) |
|
|
(1.4 |
) |
|
|
0.7 |
|
Interest income (expense) - net |
|
|
(26.0 |
) |
|
|
(1.5 |
) |
|
|
2.6 |
|
|
|
|
|
|
|
(24.9 |
) |
Equity in income of subsidiaries |
|
|
71.8 |
|
|
|
27.3 |
|
|
|
|
|
|
|
(99.1 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income before income taxes |
|
|
68.0 |
|
|
|
55.7 |
|
|
|
67.4 |
|
|
|
(100.5 |
) |
|
|
90.6 |
|
Provision for income taxes |
|
|
7.9 |
|
|
|
11.1 |
|
|
|
11.5 |
|
|
|
|
|
|
|
30.5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income |
|
$ |
60.1 |
|
|
$ |
44.6 |
|
|
$ |
55.9 |
|
|
$ |
(100.5 |
) |
|
$ |
60.1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
-19-
THE LUBRIZOL CORPORATION
Notes to Consolidated Financial Statements
June 30, 2005
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Condensed Consolidating Statement of Income |
|
|
|
Six Months Ended June 30, 2005 |
|
|
|
Parent |
|
|
Subsidiary |
|
|
Other |
|
|
|
|
|
|
Total |
|
(in millions of dollars) |
|
Company |
|
|
Guarantors |
|
|
Subsidiaries |
|
|
Eliminations |
|
|
Consolidated |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net sales |
|
$ |
661.8 |
|
|
$ |
660.1 |
|
|
$ |
1,009.4 |
|
|
$ |
(295.2 |
) |
|
$ |
2,036.1 |
|
Royalties and other revenues |
|
|
1.3 |
|
|
|
0.2 |
|
|
|
0.1 |
|
|
|
|
|
|
|
1.6 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total revenues |
|
|
663.1 |
|
|
|
660.3 |
|
|
|
1,009.5 |
|
|
|
(295.2 |
) |
|
|
2,037.7 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cost of sales |
|
|
522.3 |
|
|
|
513.1 |
|
|
|
772.0 |
|
|
|
(295.2 |
) |
|
|
1,512.2 |
|
Selling and administrative expenses |
|
|
73.2 |
|
|
|
59.3 |
|
|
|
54.8 |
|
|
|
|
|
|
|
187.3 |
|
Research, testing and development
expenses |
|
|
46.1 |
|
|
|
20.1 |
|
|
|
35.2 |
|
|
|
|
|
|
|
101.4 |
|
Amortization of intangible assets |
|
|
1.5 |
|
|
|
8.1 |
|
|
|
3.1 |
|
|
|
|
|
|
|
12.7 |
|
Restructuring charges |
|
|
4.7 |
|
|
|
2.6 |
|
|
|
4.2 |
|
|
|
|
|
|
|
11.5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total costs and expenses |
|
|
647.8 |
|
|
|
603.2 |
|
|
|
869.3 |
|
|
|
(295.2 |
) |
|
|
1,825.1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other income (expense) net |
|
|
14.4 |
|
|
|
6.8 |
|
|
|
(18.3 |
) |
|
|
(1.5 |
) |
|
|
1.4 |
|
Interest income (expense) - net |
|
|
(52.1 |
) |
|
|
(0.9 |
) |
|
|
3.6 |
|
|
|
|
|
|
|
(49.4 |
) |
Equity in income of subsidiaries |
|
|
131.9 |
|
|
|
45.2 |
|
|
|
|
|
|
|
(177.1 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income before income taxes |
|
|
109.5 |
|
|
|
108.2 |
|
|
|
125.5 |
|
|
|
(178.6 |
) |
|
|
164.6 |
|
Provision for income
taxes |
|
|
0.9 |
|
|
|
22.7 |
|
|
|
32.4 |
|
|
|
|
|
|
|
56.0 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income |
|
$ |
108.6 |
|
|
$ |
85.5 |
|
|
$ |
93.1 |
|
|
$ |
(178.6 |
) |
|
$ |
108.6 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
-20-
THE LUBRIZOL CORPORATION
Notes to Consolidated Financial Statements
June 30, 2005
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Condensed Consolidating Statement of Income |
|
|
|
Three Months Ended June 30, 2004 |
|
|
|
Parent |
|
|
Subsidiary |
|
|
Other |
|
|
|
|
|
|
Total |
|
(in millions of dollars) |
|
Company |
|
|
Guarantors |
|
|
Subsidiaries |
|
|
Eliminations |
|
|
Consolidated |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net sales |
|
$ |
319.0 |
|
|
$ |
135.8 |
|
|
$ |
368.7 |
|
|
$ |
(103.3 |
) |
|
$ |
720.2 |
|
Royalties and other revenues |
|
|
0.9 |
|
|
|
0.4 |
|
|
|
|
|
|
|
|
|
|
|
1.3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total revenues |
|
|
319.9 |
|
|
|
136.2 |
|
|
|
368.7 |
|
|
|
(103.3 |
) |
|
|
721.5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cost of sales |
|
|
234.9 |
|
|
|
108.7 |
|
|
|
289.2 |
|
|
|
(103.3 |
) |
|
|
529.5 |
|
Selling and administrative expenses |
|
|
40.2 |
|
|
|
10.8 |
|
|
|
19.2 |
|
|
|
|
|
|
|
70.2 |
|
Research, testing and development
expenses |
|
|
27.7 |
|
|
|
5.6 |
|
|
|
12.2 |
|
|
|
|
|
|
|
45.5 |
|
Amortization of intangible assets |
|
|
0.5 |
|
|
|
3.0 |
|
|
|
1.0 |
|
|
|
|
|
|
|
4.5 |
|
Write-off of acquired in-process
research and
development |
|
|
|
|
|
|
35.0 |
|
|
|
|
|
|
|
|
|
|
|
35.0 |
|
Restructuring charges |
|
|
5.7 |
|
|
|
0.6 |
|
|
|
1.7 |
|
|
|
|
|
|
|
8.0 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total costs and expenses |
|
|
309.0 |
|
|
|
163.7 |
|
|
|
323.3 |
|
|
|
(103.3 |
) |
|
|
692.7 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other income (expense) net |
|
|
7.0 |
|
|
|
3.7 |
|
|
|
(11.7 |
) |
|
|
(0.9 |
) |
|
|
(1.9 |
) |
Interest income (expense) net |
|
|
(14.0 |
) |
|
|
(3.3 |
) |
|
|
0.2 |
|
|
|
|
|
|
|
(17.1 |
) |
Equity in income of subsidiaries |
|
|
1.4 |
|
|
|
6.8 |
|
|
|
|
|
|
|
(8.2 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) before income taxes |
|
|
5.3 |
|
|
|
(20.3 |
) |
|
|
33.9 |
|
|
|
(9.1 |
) |
|
|
9.8 |
|
Provision for (benefit from)
income taxes |
|
|
1.5 |
|
|
|
(3.8 |
) |
|
|
8.2 |
|
|
|
|
|
|
|
5.9 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss) |
|
$ |
3.8 |
|
|
$ |
(16.5 |
) |
|
$ |
25.7 |
|
|
$ |
(9.1 |
) |
|
$ |
3.9 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
-21-
THE LUBRIZOL CORPORATION
Notes to Consolidated Financial Statements
June 30, 2005
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Condensed Consolidating Statement of Income |
|
|
|
Six Months Ended June 30, 2004 |
|
|
|
Parent |
|
|
Subsidiary |
|
|
Other |
|
|
|
|
|
|
Total |
|
(in millions of dollars) |
|
Company |
|
|
Guarantors |
|
|
Subsidiaries |
|
|
Eliminations |
|
|
Consolidated |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net sales |
|
$ |
615.8 |
|
|
$ |
198.4 |
|
|
$ |
682.1 |
|
|
$ |
(198.2 |
) |
|
$ |
1,298.1 |
|
Royalties and other revenues |
|
|
1.6 |
|
|
|
0.4 |
|
|
|
0.1 |
|
|
|
|
|
|
|
2.1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total revenues |
|
|
617.4 |
|
|
|
198.8 |
|
|
|
682.2 |
|
|
|
(198.2 |
) |
|
|
1,300.2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cost of sales |
|
|
452.4 |
|
|
|
156.5 |
|
|
|
545.1 |
|
|
|
(198.2 |
) |
|
|
955.8 |
|
Selling and administrative expenses |
|
|
72.8 |
|
|
|
16.6 |
|
|
|
32.6 |
|
|
|
|
|
|
|
122.0 |
|
Research, testing and development
expenses |
|
|
55.2 |
|
|
|
7.1 |
|
|
|
24.0 |
|
|
|
|
|
|
|
86.3 |
|
Amortization of intangible assets |
|
|
1.5 |
|
|
|
3.6 |
|
|
|
1.3 |
|
|
|
|
|
|
|
6.4 |
|
Write-off of acquired in-process
research and
development |
|
|
|
|
|
|
35.0 |
|
|
|
|
|
|
|
|
|
|
|
35.0 |
|
Restructuring charges |
|
|
5.7 |
|
|
|
0.6 |
|
|
|
1.7 |
|
|
|
|
|
|
|
8.0 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total costs and expenses |
|
|
587.6 |
|
|
|
219.4 |
|
|
|
604.7 |
|
|
|
(198.2 |
) |
|
|
1,213.5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other income (expense) net |
|
|
19.9 |
|
|
|
6.8 |
|
|
|
(23.0 |
) |
|
|
(1.3 |
) |
|
|
2.4 |
|
Interest income (expense) net |
|
|
(19.6 |
) |
|
|
(3.3 |
) |
|
|
0.5 |
|
|
|
|
|
|
|
(22.4 |
) |
Equity in income of subsidiaries |
|
|
21.4 |
|
|
|
8.4 |
|
|
|
|
|
|
|
(29.8 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) before income taxes |
|
|
51.5 |
|
|
|
(8.7 |
) |
|
|
55.0 |
|
|
|
(31.1 |
) |
|
|
66.7 |
|
Provision for (benifit from) income taxes |
|
|
10.0 |
|
|
|
(0.2 |
) |
|
|
15.4 |
|
|
|
|
|
|
|
25.2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss) |
|
$ |
41.5 |
|
|
$ |
(8.5 |
) |
|
$ |
39.6 |
|
|
$ |
(31.1 |
) |
|
$ |
41.5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
-22-
THE LUBRIZOL CORPORATION
Notes to Consolidated Financial Statements
June 30, 2005
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Condensed Consolidating Balance Sheet |
|
|
|
June 30, 2005 |
|
|
|
Parent |
|
|
Subsidiary |
|
|
Other |
|
|
|
|
|
|
Total |
|
(in millions of dollars) |
|
Company |
|
|
Guarantors |
|
|
Subsidiaries |
|
|
Eliminations |
|
|
Consolidated |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
ASSETS |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash and short-term investments |
|
$ |
64.2 |
|
|
$ |
7.8 |
|
|
$ |
207.0 |
|
|
$ |
|
|
|
$ |
279.0 |
|
Receivables - net |
|
|
145.0 |
|
|
|
155.1 |
|
|
|
341.0 |
|
|
|
|
|
|
|
641.1 |
|
Inventories |
|
|
88.2 |
|
|
|
181.2 |
|
|
|
319.4 |
|
|
|
(29.7 |
) |
|
|
559.1 |
|
Other current assets |
|
|
65.8 |
|
|
|
20.0 |
|
|
|
10.7 |
|
|
|
10.3 |
|
|
|
106.8 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total current assets |
|
|
363.2 |
|
|
|
364.1 |
|
|
|
878.1 |
|
|
|
(19.4 |
) |
|
|
1,586.0 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Property and equipment - net |
|
|
391.8 |
|
|
|
456.1 |
|
|
|
356.2 |
|
|
|
|
|
|
|
1,204.1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Goodwill |
|
|
27.1 |
|
|
|
677.3 |
|
|
|
443.5 |
|
|
|
|
|
|
|
1,147.9 |
|
Intangible assets net |
|
|
10.7 |
|
|
|
277.9 |
|
|
|
130.7 |
|
|
|
|
|
|
|
419.3 |
|
Investments in subsidiaries
and intercompany balances |
|
|
2,966.6 |
|
|
|
1,772.9 |
|
|
|
(249.6 |
) |
|
|
(4,489.9 |
) |
|
|
|
|
Investments in non-consolidated
companies |
|
|
5.9 |
|
|
|
1.4 |
|
|
|
|
|
|
|
|
|
|
|
7.3 |
|
Other assets |
|
|
29.8 |
|
|
|
3.1 |
|
|
|
15.5 |
|
|
|
|
|
|
|
48.4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL |
|
$ |
3,795.1 |
|
|
$ |
3,552.8 |
|
|
$ |
1,574.4 |
|
|
$ |
(4,509.3 |
) |
|
$ |
4,413.0 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
LIABILITIES AND SHAREHOLDERS
EQUITY |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Short-term debt and current
portion of long-term debt |
|
$ |
|
|
|
$ |
0.1 |
|
|
$ |
4.2 |
|
|
$ |
|
|
|
$ |
4.3 |
|
Accounts payable |
|
|
94.4 |
|
|
|
87.9 |
|
|
|
120.6 |
|
|
|
|
|
|
|
302.9 |
|
Accrued expenses and other
current liabilities |
|
|
115.1 |
|
|
|
74.4 |
|
|
|
110.4 |
|
|
|
|
|
|
|
299.9 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total current liabilities |
|
|
209.5 |
|
|
|
162.4 |
|
|
|
235.2 |
|
|
|
|
|
|
|
607.1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Long-term debt |
|
|
1,830.2 |
|
|
|
|
|
|
|
6.3 |
|
|
|
|
|
|
|
1,836.5 |
|
Postretirement health-care
obligations |
|
|
96.3 |
|
|
|
4.1 |
|
|
|
6.1 |
|
|
|
|
|
|
|
106.5 |
|
Noncurrent liabilities |
|
|
58.3 |
|
|
|
44.3 |
|
|
|
82.5 |
|
|
|
|
|
|
|
185.1 |
|
Deferred income taxes |
|
|
31.3 |
|
|
|
16.0 |
|
|
|
28.2 |
|
|
|
|
|
|
|
75.5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total liabilities |
|
|
2,225.6 |
|
|
|
226.8 |
|
|
|
358.3 |
|
|
|
|
|
|
|
2,810.7 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Minority interest in consolidated
companies |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
52.3 |
|
|
|
52.3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total shareholders equity |
|
|
1,569.5 |
|
|
|
3,326.0 |
|
|
|
1,216.1 |
|
|
|
(4,561.6 |
) |
|
|
1,550.0 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL |
|
$ |
3,795.1 |
|
|
$ |
3,552.8 |
|
|
$ |
1,574.4 |
|
|
$ |
(4,509.3 |
) |
|
$ |
4,413.0 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
-23-
THE LUBRIZOL CORPORATION
Notes to Consolidated Financial Statements
June 30, 2005
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Condensed Consolidating Balance Sheet |
|
|
|
December 31, 2004 |
|
|
|
Parent |
|
|
Subsidiary |
|
|
Other |
|
|
|
|
|
|
Total |
|
(in millions of dollars) |
|
Company |
|
|
Guarantors |
|
|
Subsidiaries |
|
|
Eliminations |
|
|
Consolidated |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
ASSETS |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash and short-term investments |
|
$ |
40.3 |
|
|
$ |
(0.1 |
) |
|
$ |
295.7 |
|
|
$ |
|
|
|
$ |
335.9 |
|
Receivables - net |
|
|
128.3 |
|
|
|
158.9 |
|
|
|
295.6 |
|
|
|
|
|
|
|
582.8 |
|
Inventories |
|
|
115.7 |
|
|
|
174.3 |
|
|
|
309.6 |
|
|
|
(30.9 |
) |
|
|
568.7 |
|
Other current assets |
|
|
67.7 |
|
|
|
20.7 |
|
|
|
11.6 |
|
|
|
10.6 |
|
|
|
110.6 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total current assets |
|
|
352.0 |
|
|
|
353.8 |
|
|
|
912.5 |
|
|
|
(20.3 |
) |
|
|
1,598.0 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Property and equipment - net |
|
|
401.0 |
|
|
|
498.3 |
|
|
|
418.6 |
|
|
|
|
|
|
|
1,317.9 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Goodwill |
|
|
27.1 |
|
|
|
633.1 |
|
|
|
493.6 |
|
|
|
|
|
|
|
1,153.8 |
|
Intangible assets - net |
|
|
11.4 |
|
|
|
286.1 |
|
|
|
139.6 |
|
|
|
|
|
|
|
437.1 |
|
Investments in subsidiaries
and intercompany balances |
|
|
3,087.0 |
|
|
|
1,625.9 |
|
|
|
(238.0 |
) |
|
|
(4,474.9 |
) |
|
|
|
|
Investments in non-consolidated
companies |
|
|
5.7 |
|
|
|
1.7 |
|
|
|
|
|
|
|
|
|
|
|
7.4 |
|
Other assets |
|
|
33.6 |
|
|
|
5.5 |
|
|
|
13.0 |
|
|
|
|
|
|
|
52.1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL |
|
$ |
3,917.8 |
|
|
$ |
3,404.4 |
|
|
$ |
1,739.3 |
|
|
$ |
(4,495.2 |
) |
|
$ |
4,566.3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
LIABILITIES AND SHAREHOLDERS
EQUITY |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Short-term debt and current
portion of long-term debt |
|
$ |
|
|
|
$ |
|
|
|
$ |
8.2 |
|
|
$ |
|
|
|
$ |
8.2 |
|
Accounts payable |
|
|
118.3 |
|
|
|
99.4 |
|
|
|
121.9 |
|
|
|
|
|
|
|
339.6 |
|
Accrued expenses and other
current liabilities |
|
|
145.0 |
|
|
|
54.8 |
|
|
|
109.7 |
|
|
|
|
|
|
|
309.5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total current liabilities |
|
|
263.3 |
|
|
|
154.2 |
|
|
|
239.8 |
|
|
|
|
|
|
|
657.3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Long-term debt |
|
|
1,957.2 |
|
|
|
|
|
|
|
6.9 |
|
|
|
|
|
|
|
1,964.1 |
|
Postretirement health-care
obligations |
|
|
96.3 |
|
|
|
3.9 |
|
|
|
6.2 |
|
|
|
|
|
|
|
106.4 |
|
Noncurrent liabilities |
|
|
47.5 |
|
|
|
40.5 |
|
|
|
82.7 |
|
|
|
|
|
|
|
170.7 |
|
Deferred income taxes |
|
|
16.0 |
|
|
|
41.7 |
|
|
|
33.0 |
|
|
|
|
|
|
|
90.7 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total liabilities |
|
|
2,380.3 |
|
|
|
240.3 |
|
|
|
368.6 |
|
|
|
|
|
|
|
2,989.2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Minority interest in consolidated
companies |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
53.6 |
|
|
|
53.6 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total shareholders equity |
|
|
1,537.5 |
|
|
|
3,164.1 |
|
|
|
1,370.7 |
|
|
|
(4,548.8 |
) |
|
|
1,523.5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL |
|
$ |
3,917.8 |
|
|
$ |
3,404.4 |
|
|
$ |
1,739.3 |
|
|
$ |
(4,495.2 |
) |
|
$ |
4,566.3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
-24-
THE LUBRIZOL CORPORATION
Notes to Consolidated Financial Statements
June 30, 2005
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Condensed Consolidating Statement of Cash Flows |
|
|
|
Six Months Ended June 30, 2005 |
|
|
|
Parent |
|
|
Subsidiary |
|
|
Other |
|
|
|
|
|
|
Total |
|
(in millions of dollars) |
|
Company |
|
|
Guarantors |
|
|
Subsidiaries |
|
|
Eliminations |
|
|
Consolidated |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
CASH PROVIDED BY (USED FOR): |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
OPERATING ACTIVITIES: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income |
|
$ |
108.6 |
|
|
$ |
85.5 |
|
|
$ |
93.1 |
|
|
$ |
(178.6 |
) |
|
$ |
108.6 |
|
Adjustments to reconcile net income to
cash provided by
(used for) operating
activities |
|
|
16.5 |
|
|
|
38.7 |
|
|
|
(201.8 |
) |
|
|
178.6 |
|
|
|
32.0 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total operating activities |
|
|
125.1 |
|
|
|
124.2 |
|
|
|
(108.7 |
) |
|
|
|
|
|
|
140.6 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
INVESTING ACTIVITIES: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Capital expenditures |
|
|
(21.2 |
) |
|
|
(16.3 |
) |
|
|
(21.1 |
) |
|
|
|
|
|
|
(58.6 |
) |
Other items net |
|
|
(0.4 |
) |
|
|
3.4 |
|
|
|
0.2 |
|
|
|
|
|
|
|
3.2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total investing activities |
|
|
(21.6 |
) |
|
|
(12.9 |
) |
|
|
(20.9 |
) |
|
|
|
|
|
|
(55.4 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
FINANCING ACTIVITIES: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Changes in short-term debt net |
|
|
|
|
|
|
|
|
|
|
(3.7 |
) |
|
|
|
|
|
|
(3.7 |
) |
Repayments of long-term debt |
|
|
(125.0 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(125.0 |
) |
Dividends paid |
|
|
(35.0 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(35.0 |
) |
Changes in intercompany activities |
|
|
42.9 |
|
|
|
(100.9 |
) |
|
|
58.0 |
|
|
|
|
|
|
|
|
|
Proceeds from the exercise of stock
options |
|
|
37.4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
37.4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total financing activities |
|
|
(79.7 |
) |
|
|
(100.9 |
) |
|
|
54.3 |
|
|
|
|
|
|
|
(126.3 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Effect of exchange rate changes on cash |
|
|
|
|
|
|
(2.4 |
) |
|
|
(13.4 |
) |
|
|
|
|
|
|
(15.8 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net increase (decrease) in cash and
short-term investments |
|
|
23.8 |
|
|
|
8.0 |
|
|
|
(88.7 |
) |
|
|
|
|
|
|
(56.9 |
) |
Cash and short-term investments at
beginning of period |
|
|
40.4 |
|
|
|
(0.2 |
) |
|
|
295.7 |
|
|
|
|
|
|
|
335.9 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash and short-term investments at
end of period |
|
$ |
64.2 |
|
|
$ |
7.8 |
|
|
$ |
207.0 |
|
|
$ |
|
|
|
$ |
279.0 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
-25-
THE LUBRIZOL CORPORATION
Notes to Consolidated Financial Statements
June 30, 2005
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Condensed Consolidating Statement of Cash Flows |
|
|
|
Six Months Ended June 30, 2004 |
|
|
|
Parent |
|
|
Subsidiary |
|
|
Other |
|
|
|
|
|
|
Total |
|
(in millions of dollars) |
|
Company |
|
|
Guarantors |
|
|
Subsidiaries |
|
|
Eliminations |
|
|
Consolidated |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
CASH PROVIDED BY (USED FOR): |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
OPERATING ACTIVITIES: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income |
|
$ |
41.5 |
|
|
$ |
(8.5 |
) |
|
$ |
39.6 |
|
|
$ |
(31.1 |
) |
|
$ |
41.5 |
|
Adjustments to reconcile net income to
cash provided by (used
for) operating
activities |
|
|
13.2 |
|
|
|
(26.5 |
) |
|
|
36.9 |
|
|
|
31.1 |
|
|
|
54.7 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total operating activities |
|
|
54.7 |
|
|
|
(35.0 |
) |
|
|
76.5 |
|
|
|
|
|
|
|
96.2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
INVESTING ACTIVITIES: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Capital expenditures |
|
|
(23.8 |
) |
|
|
(6.2 |
) |
|
|
(12.2 |
) |
|
|
|
|
|
|
(42.2 |
) |
Acquisitions - net of cash received and
liabilities assumed |
|
|
(20.3 |
) |
|
|
(827.7 |
) |
|
|
(112.7 |
) |
|
|
|
|
|
|
(960.7 |
) |
Other items net |
|
|
(0.1 |
) |
|
|
|
|
|
|
0.1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total investing activities |
|
|
(44.2 |
) |
|
|
(833.9 |
) |
|
|
(124.8 |
) |
|
|
|
|
|
|
(1,002.9 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
FINANCING ACTIVITIES: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Changes in short-term debt net |
|
|
1,797.0 |
|
|
|
9.8 |
|
|
|
(6.7 |
) |
|
|
|
|
|
|
1,800.1 |
|
Repayments of long-term debt |
|
|
(18.4 |
) |
|
|
(908.5 |
) |
|
|
(8.0 |
) |
|
|
|
|
|
|
(934.9 |
) |
Long-term borrowings |
|
|
25.0 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
25.0 |
|
Dividends paid |
|
|
(26.8 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(26.8 |
) |
Changes in intercompany activities |
|
|
(1,821.0 |
) |
|
|
1,774.6 |
|
|
|
46.4 |
|
|
|
|
|
|
|
|
|
Proceeds from the exercise of stock
options |
|
|
5.5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5.5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total financing activities |
|
|
(38.7 |
) |
|
|
875.9 |
|
|
|
31.7 |
|
|
|
|
|
|
|
868.9 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Effect of exchange rate changes on cash |
|
|
6.4 |
|
|
|
0.2 |
|
|
|
(0.2 |
) |
|
|
|
|
|
|
6.4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net
(decrease) increase in cash and short-term
investments |
|
|
(21.8 |
) |
|
|
7.2 |
|
|
|
(16.8 |
) |
|
|
|
|
|
|
(31.4 |
) |
Cash and short-term investments at
beginning of period |
|
|
56.2 |
|
|
|
(1.0 |
) |
|
|
203.5 |
|
|
|
|
|
|
|
258.7 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash and short-term investments at
end of period |
|
$ |
34.4 |
|
|
$ |
6.2 |
|
|
$ |
186.7 |
|
|
$ |
|
|
|
$ |
227.3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
-26-
Item 2. Managements Discussion and Analysis of Financial Condition and Results of Operations
This Managements Discussion and Analysis of Financial Condition and Results of Operations
should be read in conjunction with the unaudited consolidated financial statements and the notes
thereto appearing elsewhere in this quarterly report on Form 10-Q. Historical results and
percentage relationships set forth in the consolidated financial statements, including trends that
might appear, should not be taken as indicative of future operations. The following discussion
contains forward-looking statements that involve risk and uncertainties. Our actual results may
differ materially from those discussed in such forward-looking statements as a result of various
factors, including those described under the section Cautionary Statements for Safe Harbor
Purposes included elsewhere in this quarterly report on Form 10-Q.
OVERVIEW
We are an innovative specialty chemical company that produces and supplies technologies that
improve the quality and performance of our customers products in the global transportation,
industrial and consumer markets. Our business is founded on technological leadership. Innovation
provides opportunities for us in growth markets as well as advantages over our competitors. From a
base of approximately 2,400 patents, we use our product development and formulation expertise to
sustain our leading market positions and fuel our future growth. We create additives, ingredients,
resins and compounds that enhance the performance, quality and value of our customers products,
while minimizing their environmental impact. Our products are used in a broad range of
applications, and are sold into stable markets such as those for engine oils, specialty driveline
lubricants and metalworking fluids, as well as higher-growth markets such as personal care and
pharmaceutical products and performance coatings and inks. Our specialty materials products are
also used in a variety of industries, including the construction, sporting goods, medical products
and automotive industries. We are an industry leader in the majority of our product lines.
We are geographically diverse, with an extensive global manufacturing, supply chain, technical and
commercial infrastructure. We operate facilities in 27 countries, comprised of production
facilities in 21 countries and laboratories in 11 countries, through the efforts of more than 7,700
employees. We sell our products in more than 100 countries and believe that our customers value
our ability to provide customized, high-quality, cost-effective performance formulations and
solutions worldwide. We also believe that our customers value our global supply chain
capabilities.
On June 3, 2004, we completed the acquisition of Noveon International, Inc. (Noveon International),
a leading global producer and marketer of technologically advanced specialty materials and
chemicals used in the industrial and consumer markets. With the acquisition of Noveon
International, we have accelerated our program to attain a substantial presence in the personal
care and coatings markets by adding a number of higher-growth, industry-leading products under
highly recognizable brand names, including Carbopol®, to our already strong portfolio of
lubricant and fuel additives, and consumer products. Additionally, Noveon International has a
number of industry-leading and strong, cash flow-generating specialty materials businesses,
including TempRite® chlorinated polyvinyl chloride (CPVC) and Estane®
thermoplastic polyurethane (TPU).
We acquired Noveon International for cash of $920.2 million (inclusive of certain seller expenses
of $32.9 million) plus transaction costs of $11.4 million and less cash acquired of $103.0 million.
In addition, we assumed $1,103.1 million of long-term indebtedness from Noveon International.
We initially financed the acquisition and related costs with the proceeds of a $2,450.0 million
364-day bridge credit facility. Shortly after the acquisition, we repaid substantially all of the
assumed long-term debt with proceeds of the temporary bridge loan. In addition, we repaid the
temporary bridge loan in full in September 2004 when we secured our permanent financing that
included the issuance of senior notes, debentures, bank term loans and equity.
-27-
Item 2. Managements Discussion and Analysis of Financial Condition and Results of Operations (continued)
Our consolidated balance sheets as of June 30, 2005 and December 31, 2004 reflect the acquisition
of Noveon International under the purchase method of accounting. We recorded the various assets
acquired and liabilities assumed, primarily working capital accounts, of Noveon International at
their estimated fair values determined as of the acquisition date. Actuarial valuations were
completed for the projected pension and other post-employment benefit obligations and were
reflected in the purchase price allocation. We also obtained appraisals of long-lived assets and
identifiable intangible assets, including an evaluation of in-process research and development
(IPR&D) projects. Through June 2005, we were still finalizing certain aspects of the purchase
price allocation primarily surrounding the valuation of the property, plant and equipment and the
deferred tax accounts. In connection with the acquisition of Noveon International, we have
targeted non-core businesses with total revenues of approximately $500.0 million for disposition.
This plan was contemplated at the time of acquisition and plan activities have been underway since
the fourth quarter of 2004. In addition, through June 2005, we were still in the process of
finalizing the reconciliation of the underlying fixed-asset records to the respective appraisals.
As a result of both of these efforts, in the six months ended June 30, 2005, we reduced the amount
allocated to property, plant and equipment by $55.2 million since December 31, 2004. Depreciation
expense for the three and six months ended June 30, 2005 included a related adjustment of $1.1
million and $2.3 million, respectively, representing the change in depreciation expense associated
with the change in the estimated fair values assigned to property, plant and equipment. In
addition, the deferred tax accounts were adjusted in June 2005 resulting in a decrease of $17.7
million to the net deferred tax liabilities since December 31, 2004. The goodwill associated with
the transaction increased by $33.7 million in the six months ended June 30, 2005 representing the
net impact of all adjustments recorded. The allocation of the purchase price was complete as of
June 30, 2005 and the related actuarial valuations and appraisals obtained have been finalized.
The purchase price included the estimated fair value of IPR&D projects totaling $34.0 million that,
as of the acquisition date, had not yet reached technological feasibility and had no alternative
future use. As a result, the full amount allocated to IPR&D was expensed in 2004. The amount
charged to expense in the second quarter of 2004 was $35.0 million. This amount subsequently was
adjusted to $34.0 million in the second half of 2004. There have been no changes to the valuation
of IPR&D in 2005. The inventory step-up to fair value totaled $24.2 million, of which $4.9 million
was expensed in the second quarter of 2004. As the remaining step-up relates to inventories
accounted for on the LIFO method of accounting, we do not anticipate that additional amounts of
step-up will be expensed in the near term.
In 2005, we have continued to integrate the Noveon International acquisition ahead of schedule. We
are projecting to realize savings of approximately $40.0 million by the end of 2005, which is two
years ahead of schedule. In addition, we believe we are currently saving at an annual run-rate of
approximately $45.0 million as compared to our original run-rate target of $40.0 million.
In conjunction with the integration of Noveon International, we have also made progress in our plan
to divest non-core businesses. In 2005, we selected investment bankers to assist us with the
process. We have distributed offering memoranda for some of the businesses and we are planning to
distribute offering materials for the rest of the businesses in the third quarter of 2005. We do
not believe the businesses or assets we are evaluating are considered held for sale pursuant to the
provisions of Statement of Financial Accounting Standards (SFAS) No. 144, Accounting for the
Impairment or Disposal of Long-Lived Assets, as of June 30, 2005.
-28-
Item 2. Managements Discussion and Analysis of Financial Condition and Results of Operations (continued)
RESULTS OF OPERATIONS
Our net income for the three months ended June 30, 2005 increased over the prior-year period as
improved price and product mix, the Noveon International acquisition, favorable currency, lower
STAR (selling, testing, administrative and research) expenses, higher shipment volume and a lower
tax rate more than offset higher raw material costs. The increase in net income for the three and
six months ended June 30, 2005 as compared to the prior-year periods was due in part to the
significant non-recurring charges associated with the Noveon International purchase accounting that
included the write-off of IPR&D of $35.0 million and inventory step-up amortization of $4.9 million
partially offset by a gain on a foreign currency forward contract of $6.4 million incurred in the
six months ended June 30, 2004. Excluding the impact associated with the Noveon International
acquisition, the related purchase accounting and the currency forward contract, the increase in net
income for the first half of the year primarily was attributed to improved price and product mix,
favorable currency, lower STAR expenses and a lower tax rate that more than offset higher raw
material costs and lower shipment volumes. The acquisition of Noveon International in June 2004
contributed $0.05 and $0.10 to earnings per share for the three and six months ended June 30, 2005,
respectively, after considering incremental equity issuances and financing costs. The company
recorded restructuring charges that reduced earnings by $0.06 and $0.12 per share for the three and
six months ended June 30, 2005, respectively, primarily related to the phase-out of manufacturing
facilities located in Bromborough, United Kingdom; Linden, New Jersey; and Mountaintop,
Pennsylvania, as well as other workforce reductions. A restructuring charge of $.10 per share was
incurred in the three and six months ended June 30, 2004 primarily related to the restructuring
initiated after the acquisition of Noveon International.
Revenues
The changes in consolidated revenues are summarized as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Periods Ended |
|
|
|
|
|
|
|
|
|
|
Excluding |
|
|
|
|
June 30, |
|
|
|
|
|
|
|
|
|
|
Acquisitions |
|
(in millions of dollars) |
|
2005 |
|
|
2004 |
|
|
$ Change |
|
|
% Change |
|
$ Change |
|
|
% Change |
|
|
Three Months: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net sales |
|
$ |
1,066.0 |
|
|
$ |
720.2 |
|
|
$ |
345.8 |
|
|
|
48 |
% |
|
$ |
110.4 |
|
|
|
15 |
% |
|
Royalties and other
revenues |
|
|
0.6 |
|
|
|
1.3 |
|
|
|
(0.7 |
) |
|
|
(54 |
%) |
|
|
(0.7 |
) |
|
|
(54 |
%) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total revenues |
|
$ |
1,066.6 |
|
|
$ |
721.5 |
|
|
$ |
345.1 |
|
|
|
48 |
% |
|
$ |
109.7 |
|
|
|
15 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Six Months: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net sales |
|
$ |
2,036.1 |
|
|
$ |
1,298.1 |
|
|
$ |
738.0 |
|
|
|
57 |
% |
|
$ |
146.9 |
|
|
|
11 |
% |
|
Royalties and other
revenues |
|
|
1.6 |
|
|
|
2.1 |
|
|
|
(0.5 |
) |
|
|
(24 |
%) |
|
|
(0.6 |
) |
|
|
(28 |
%) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total revenues |
|
$ |
2,037.7 |
|
|
$ |
1,300.2 |
|
|
$ |
737.5 |
|
|
|
57 |
% |
|
$ |
146.3 |
|
|
|
11 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The acquisition of Noveon International accounted for a significant portion of the increase in
consolidated revenues for both periods presented. The 2004 acquisitions of Noveon International
and the hyperdispersants business purchased from Avecia contributed $235.4 million and $591.2
million toward the increase in revenues for the three and six months ended June 30, 2005,
respectively, as compared with the same periods in 2004.
Excluding acquisitions, the increase in revenues for both the three and six months ended June 30,
2005 primarily was due to an improvement in price and product mix resulting from the cumulative
impact of a series of price increases over the past year, as well as favorable currency.
-29-
Item 2. Managements Discussion and Analysis of Financial Condition and Results of Operations (continued)
The following table shows our shipment volume by geographic zone for the three and six months ended
June 30, 2005.
|
|
|
|
|
|
|
|
|
|
|
2nd Quarter |
|
Year-to-Date |
|
|
2005 |
|
2005 |
|
|
Volume |
|
Volume |
North America |
|
|
49 |
% |
|
|
50 |
% |
Europe |
|
|
25 |
% |
|
|
26 |
% |
Asia-Pacific / Middle East |
|
|
21 |
% |
|
|
19 |
% |
Latin America |
|
|
5 |
% |
|
|
5 |
% |
|
|
|
|
|
Total |
|
|
100 |
% |
|
|
100 |
% |
|
|
|
|
|
The following table shows the changes in our shipment volume by geographic zone as compared with
the corresponding periods in 2005.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Excluding |
|
|
|
|
|
|
Acquisitions |
|
|
2005 vs. 2004 |
|
2005 vs. 2004 |
|
|
% Change |
|
% Change |
Second Quarter: |
|
|
|
|
|
|
|
|
North America |
|
|
23 |
% |
|
|
(7 |
%) |
Europe |
|
|
14 |
% |
|
|
4 |
% |
Asia-Pacific / Middle East |
|
|
25 |
% |
|
|
13 |
% |
Latin America |
|
|
14 |
% |
|
|
(2 |
%) |
Total |
|
|
20 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
Year-to-Date: |
|
|
|
|
|
|
|
|
North America |
|
|
31 |
% |
|
|
(9 |
%) |
Europe |
|
|
18 |
% |
|
|
4 |
% |
Asia-Pacific / Middle East |
|
|
21 |
% |
|
|
6 |
% |
Latin America |
|
|
11 |
% |
|
|
(8 |
%) |
Total |
|
|
25 |
% |
|
|
(3 |
%) |
Segment shipment volume variances by geographic zone as well as the factors explaining the changes
in segment revenues for both the three and six months ended June 30, 2005 compared with the
respective periods in 2004 are contained under the Segment Analysis section below.
Costs and Expenses
The changes in consolidated costs and expenses are summarized as follows:
-30-
Item 2. Managements Discussion and Analysis of Financial Condition and Results of Operations (continued)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Periods Ended |
|
|
|
|
|
|
|
|
|
|
Excluding |
|
|
|
June 30, |
|
|
|
|
|
|
|
|
|
|
Acquisitions |
|
(in millions of dollars) |
|
2005 |
|
|
2004 |
|
|
$ Change |
|
|
% Change |
|
$ Change |
|
|
% Change |
Three Months: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cost of sales |
|
$ |
795.1 |
|
|
$ |
529.5 |
|
|
$ |
265.6 |
|
|
|
50 |
% |
|
$ |
94.1 |
|
|
|
18 |
% |
Selling and administrative
expenses |
|
|
94.3 |
|
|
|
70.2 |
|
|
|
24.1 |
|
|
|
34 |
% |
|
|
(0.1 |
) |
|
|
|
|
Research, testing and
development expenses |
|
|
50.9 |
|
|
|
45.5 |
|
|
|
5.4 |
|
|
|
12 |
% |
|
|
(3.5 |
) |
|
|
(8 |
%) |
Amortization of
intangible assets |
|
|
6.1 |
|
|
|
4.5 |
|
|
|
1.6 |
|
|
|
* |
|
|
|
(1.0 |
) |
|
|
* |
|
Write-off of acquired
IPR&D |
|
|
|
|
|
|
35.0 |
|
|
|
(35.0 |
) |
|
|
* |
|
|
|
(35.0 |
) |
|
|
* |
|
Restructuring charges |
|
|
5.4 |
|
|
|
8.0 |
|
|
|
(2.6 |
) |
|
|
* |
|
|
|
(3.7 |
) |
|
|
* |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total costs and expenses |
|
$ |
951.8 |
|
|
$ |
692.7 |
|
|
$ |
259.1 |
|
|
|
37 |
% |
|
$ |
50.8 |
|
|
|
7 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Six Months: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cost of sales |
|
$ |
1,512.2 |
|
|
$ |
955.8 |
|
|
$ |
556.4 |
|
|
|
58 |
% |
|
$ |
127.6 |
|
|
|
13 |
% |
Selling and administrative
expenses |
|
|
187.3 |
|
|
|
122.0 |
|
|
|
65.3 |
|
|
|
54 |
% |
|
|
4.6 |
|
|
|
4 |
% |
Research, testing and
development expenses |
|
|
101.4 |
|
|
|
86.3 |
|
|
|
15.1 |
|
|
|
17 |
% |
|
|
(7.0 |
) |
|
|
(8 |
%) |
Amortization of
intangible assets |
|
|
12.7 |
|
|
|
6.4 |
|
|
|
6.3 |
|
|
|
* |
|
|
|
(1.0 |
) |
|
|
* |
|
Write-off of acquired
IPR&D |
|
|
|
|
|
|
35.0 |
|
|
|
(35.0 |
) |
|
|
* |
|
|
|
(35.0 |
) |
|
|
* |
|
Restructuring charges |
|
|
11.5 |
|
|
|
8.0 |
|
|
|
3.5 |
|
|
|
* |
|
|
|
1.7 |
|
|
|
* |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total costs and expenses |
|
$ |
1,825.1 |
|
|
$ |
1,213.5 |
|
|
$ |
611.6 |
|
|
|
50 |
% |
|
$ |
90.9 |
|
|
|
7 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
*Calculation not meaningful
Excluding acquisitions, the increase in cost of sales for the three and six months ended June
30, 2005 compared with the same periods in 2004 primarily was due to higher average raw material
cost and higher manufacturing expenses. Excluding acquisitions, average raw material cost
increased 19% and 18% in the three and six months ended June 30, 2005 compared with the same
periods in 2004, primarily due to higher unit raw material cost along with unfavorable currency
effects. In June 2004, we also recorded a purchase accounting adjustment associated with the
increased valuation of Noveon International-acquired inventory of $4.9 million. We expect higher
raw material costs in the third quarter of 2005 as compared to the second quarter of 2005. |
-31-
Item 2. Managements Discussion and Analysis of Financial Condition and Results of Operations (continued)
Excluding acquisitions, total manufacturing expenses, which are included in cost of sales,
increased 7% and 6% (increased 43% and 55%, respectively, including acquisitions) in the three and
six months ended June 30, 2005, respectively, compared with the same periods in 2004. Excluding
acquisitions, we estimate that currency accounted for approximately 20% and 44% of the increase for
the three and six months ended June 30, 2005, respectively. The remainder of the increase for the
three-month period primarily was due to an increase in utilities and an increase due to the timing
of maintenance activities. The remainder of the increase for the six-month period primarily was
due to an increase in utility costs, an increase in maintenance activities, offset by a $2.0
million environmental charge incurred in the first quarter of 2004 that did not recur in 2005. On
a per-unit-sold basis, manufacturing costs increased 8% and 5% in the three and six months ended
June 30, 2005, respectively, excluding acquisitions, compared to the prior-year periods.
Gross profit (net sales less cost of sales) increased $80.2 million, or 42% ($16.3 million, or 9%,
excluding acquisitions), and $181.6 million, or 53% ($19.3 million, or 6%, excluding acquisitions),
in the three and six months ended June 30, 2005, respectively, compared with the same periods in
2004. Excluding acquisitions, the increase primarily was due to higher average selling price
partially offset by higher average raw material cost. In addition, increased sales from our
equipment companies contributed to the higher gross profit for the periods. Our gross profit
percentage (gross profit divided by net sales) decreased to 25.4% in the second quarter of 2005
(24.9% excluding acquisitions) compared to 26.5% in the second quarter of 2004. The gross profit
percentage decrease, excluding acquisitions, primarily was due to the impact of increasing unit raw
material costs compared to similar increases in per unit sales prices.
The increase in selling and administrative expenses, excluding acquisitions, for the six months
ended June 30, 2005 primarily was due to higher compensation expense and unfavorable currency. We
experienced an increase in compensation-related costs due to increases in variable compensation and
annual salaries. In addition, we estimate that currency accounted for approximately 25% of the
total increase.
The decrease in research, testing and development expenses (technology expenses), excluding
acquisitions, for both the three and six months ended June 30, 3005 primarily was due to a decrease
in testing at outside laboratories of $0.7 million and $3.0 million, respectively, compared to the
same periods in 2004. In addition, there was a $1.5 million and $2.1 million reduction in salary
and benefit expenses for the three- and six-month comparable periods primarily as a result of the
2004 reduction in workforce. We anticipate higher testing expenses in the second half of 2005 as
we increase testing for the next North American diesel engine oil upgrade.
In the three and six months ended June 30, 3004, we recorded a one-time, non-cash charge of $35.0
million, or $0.42 per share, in total costs and expenses to write-off the estimated fair value of
IPR&D projects associated with the Noveon International acquisition. Costs to acquire IPR&D
projects that have no future alternative use and that have not yet reached technological
feasibility at the date of acquisition are expensed upon acquisition. This amount was subsequently
adjusted to $34.0 million in the second half of 2004. No further adjustments were made in 2005 to
the valuation in connection with the completion of the Noveon International purchase accounting.
In the three and six months ended June 30, 2005, we recorded restructuring charges aggregating $5.4
million, or $0.06 per share, and $11.5 million, or $.12 per share, primarily related to the
phase-out of three manufacturing facilities in both the Lubricant Additives and Specialty Chemicals
segments, as well as other workforce reductions. The components of the 2005 restructuring charges
are detailed as follows:
-32-
Item 2. Managements Discussion and Analysis of Financial Condition and Results of Operations (continued)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Periods Ended June 30, 2005 |
|
|
|
Asset |
|
|
Other Plant Exit |
|
|
|
|
|
|
|
(in millions of dollars) |
|
Impairments |
|
|
Costs |
|
|
Severance |
|
|
Total |
|
Three Months: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Coatings plant closures
and workforce reductions |
|
$ |
|
|
|
$ |
0.5 |
|
|
$ |
1.7 |
|
|
$ |
2.2 |
|
Bromborough, United Kingdom closure |
|
|
0.7 |
|
|
|
0.3 |
|
|
|
1.5 |
|
|
|
2.5 |
|
Corporate workforce reductions |
|
|
|
|
|
|
|
|
|
|
0.7 |
|
|
|
0.7 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
0.7 |
|
|
$ |
0.8 |
|
|
$ |
3.9 |
|
|
$ |
5.4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Six Months: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Coatings plant closures
and workforce reductions |
|
$ |
4.4 |
|
|
$ |
0.9 |
|
|
$ |
1.8 |
|
|
$ |
7.1 |
|
Bromborough, United Kingdom closure |
|
|
0.7 |
|
|
|
0.5 |
|
|
|
2.2 |
|
|
|
3.4 |
|
Corporate workforce reductions |
|
|
|
|
|
|
|
|
|
|
0.7 |
|
|
|
0.7 |
|
Noveon International restructuring
liabilities |
|
|
|
|
|
|
|
|
|
|
0.3 |
|
|
|
0.3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
5.1 |
|
|
$ |
1.4 |
|
|
$ |
5.0 |
|
|
$ |
11.5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
In May 2005, we announced the reorganization of the Specialty Chemicals performance coatings
product line. This product line includes businesses acquired from Noveon International as well as
businesses included in our legacy operations. In connection with the reorganization, we eliminated
14 positions in North America and Europe. These reductions were completed by June 30, 2005 and
resulted in a severance-related charge of $1.1 million recorded in the three and six months ended
June 30, 2005.
In the first quarter of 2005, we made the decision to close two Specialty Chemicals performance
coatings production facilities in the United States. The aggregate restructuring charge recorded
for these closures for the three months ended June 30, 2005 was $1.1 million, comprised of $0.5
million in exit costs and $0.6 million in severance costs. The aggregate restructuring charge
recorded for these closures for the six months ended June 30, 2005 was $6.0 million, comprised of
$4.4 million in asset impairments, $0.9 million in exit costs and $0.7 million in severance costs.
We estimate we will incur cumulative severance costs of approximately $2.1 million relating to
these closures. An impairment charge for both plants was recorded in the first quarter of 2005 to
reflect the related assets at their estimated fair values. The estimated fair value of the assets
primarily was determined from third-party appraisals. Production for these sites will be
transferred to other facilities in the United States. The facility in Mountaintop, Pennsylvania is
scheduled to close in the third quarter of 2005. The facility in Linden, New Jersey is scheduled
to close in the second quarter of 2006. These closures will result in a workforce reduction of 62
employees by the second quarter of 2006.
In December 2004, we made the decision to close the Lubricant Additives manufacturing facility in
Bromborough, United Kingdom. We announced this decision in January 2005. We determined, as of
December 31, 2004, that an impairment of certain of the facilitys long-lived assets had been
triggered by this decision in the fourth quarter of 2004. As a result, a $17.0 million impairment
charge was recorded in December 2004 to reflect the related assets at their estimated fair values.
Production phase-out of this site is planned to begin in the third quarter of 2005 and is expected
to be completed by late 2006. During this phase-out, United Kingdom production will be transferred
to facilities in France and the United States. Approximately 69 employees will be impacted by this
closure. The aggregate restructuring charge recorded for this closure for the three months ended
June 30, 2005 was $2.5 million, comprised of $0.7 million in asset impairments, $0.3 million in
exit costs and $1.5 million in severance costs. The
-33-
Item 2. Managements Discussion and Analysis of Financial Condition and Results of Operations (continued)
aggregate restructuring charge recorded for this closure for the six months ended June 30, 2005 was
$3.4 million, comprised of $0.7 million in asset impairments, $0.5 million in exit costs and $2.2
million in severance costs. We currently anticipate that pre-tax charges for cash expenditures of
approximately $13.5 million to $15.5 million will be incurred in 2005 through 2007 to satisfy
severance and retention obligations, plant dismantling, site restoration and other site
environmental evaluation costs and lease-related costs, including the $2.7 million recorded through
June 30, 2005.
In addition to the restructuring charges recorded for the above facilities, we also expect to
invest approximately $1.4 million relating to the two Specialty Chemicals plants and $20.0 million
for Bromborough over the next two years for capacity upgrades at alternative manufacturing
facilities that will absorb production previously undertaken at these
facilities. We expect these workforce reductions,
facility closures and transfer of production to more efficient manufacturing locations to generate
annual pre-tax savings of approximately $3.2 million for Specialty Chemicals and $10.0 million for
Bromborough by 2007.
In 2004, we eliminated more than 100 positions, primarily affecting technical and commercial
employees located at the Wickliffe, Ohio headquarters. Most of these workforce reductions related
to the restructuring following the acquisition of Noveon International and were completed by
December 31, 2004. The restructuring charge of $8.0 million, or $0.10 per share, recorded in the
three and six months ended June 30, 2004 related to these reductions. These reductions resulted in
$4.6 million and $9.1 million in pre-tax savings in the three and six months ended June 30, 2005,
respectively. We estimate future annual pre-tax savings will be approximately $18.3 million. In
the second quarter of 2005, we began a process of identifying further opportunities to increase
efficiency and productivity, reduce costs and support our integration strategy of the Noveon
International acquisition. As a result, we reduced headcount in the general and administrative
area of our headquarters offices in Ohio. Through these restructuring efforts, we eliminated
seven positions resulting in a severance-related charge of $0.7 million. All of the affected
employees had left their positions by June 30, 2005 and the remaining personnel-related costs are
expected to be paid by 2006. We will continue to evaluate other opportunities to integrate general
and administrative functions. As such opportunities are identified in future periods, we expect
further restructuring charges.
-34-
Item 2. Managements Discussion and Analysis of Financial Condition and Results of Operations (continued)
Other Items and Net Income
The changes in other items and net income are summarized as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Periods Ended |
|
|
|
|
|
|
|
|
|
|
Excluding |
|
|
|
June 30, |
|
|
|
|
|
|
|
|
|
|
Acquisitions |
|
(in millions of dollars) |
|
2005 |
|
|
2004 |
|
|
$ Change |
|
|
% Change |
|
$ Change |
|
|
% Change |
Three Months: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other income (expense) -
net |
|
$ |
0.7 |
|
|
$ |
(1.9 |
) |
|
$ |
2.6 |
|
|
|
* |
|
|
$ |
2.1 |
|
|
|
* |
|
Interest expense - net |
|
|
(24.9 |
) |
|
|
(17.1 |
) |
|
|
(7.8 |
) |
|
|
* |
|
|
|
(5.7 |
) |
|
|
* |
|
Income before income
taxes |
|
|
90.6 |
|
|
|
9.8 |
|
|
|
80.8 |
|
|
|
* |
|
|
|
66.7 |
|
|
|
* |
|
Provision for income
taxes |
|
|
30.5 |
|
|
|
5.9 |
|
|
|
24.6 |
|
|
|
* |
|
|
|
20.1 |
|
|
|
* |
|
Net income |
|
|
60.1 |
|
|
|
3.9 |
|
|
|
56.2 |
|
|
|
* |
|
|
|
46.6 |
|
|
|
* |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Six Months: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other income (expense) -
net |
|
$ |
1.4 |
|
|
$ |
2.4 |
|
|
$ |
(1.0 |
) |
|
|
* |
|
|
$ |
(1.7 |
) |
|
|
* |
|
Interest expense - net |
|
|
(49.4 |
) |
|
|
(22.4 |
) |
|
|
(27.0 |
) |
|
|
* |
|
|
|
(6.6 |
) |
|
|
* |
|
Income before income
taxes |
|
|
164.6 |
|
|
|
66.7 |
|
|
|
97.9 |
|
|
|
147 |
% |
|
|
60.3 |
|
|
|
90 |
% |
Provision for income
taxes |
|
|
56.0 |
|
|
|
25.2 |
|
|
|
30.8 |
|
|
|
122 |
% |
|
|
18.0 |
|
|
|
71 |
% |
Net income |
|
|
108.6 |
|
|
|
41.5 |
|
|
|
67.1 |
|
|
|
162 |
% |
|
|
42.3 |
|
|
|
102 |
% |
*Calculation not meaningful
The changes in net other income (expense) for the three and six months ended June 30, 2005,
respectively, compared to the same periods in 2004, primarily were due to fluctuations in net
translation gains (losses) of $3.5 million for the three-month period and ($1.5) million for the
six-month period. In addition, net other income for the six months ended June 30, 2004 included a
gain of $6.4 million, or $0.08 per share, on a currency forward contract to purchase pound sterling
related to the acquisition of the hyperdispersants business. We secured the forward contract in
December 2003 and completed the acquisition at the end of January 2004.
The increase in net interest expense for both the three and six months ended June 30, 2005
primarily was due to the Noveon International acquisition-related financing costs. These financing
costs for the three and six months ended June 30, 2005 were $41.7 million and $21.0 million,
respectively, compared to $12.2 million for both the three and six months ended June 30, 2004. The
2004 amount was comprised of bridge loan and Noveon International interest of $6.5 million,
amortization of bridge loan fees of $2.8 million and termination of an interest swap of $2.9
million. We obtained permanent transaction financing for the Noveon International acquisition in
the third quarter of 2004, of which the debt component had a weighted average interest rate of 5.3%
in the first half of 2005.
-35-
Item 2. Managements Discussion and Analysis of Financial Condition and Results of Operations (continued)
We had an effective tax rate of 33.6% and 34.0% for the three and six months ended June 30, 2005,
respectively, compared with 59.8% and 37.8% in the same periods in 2004. The effective tax rate
for the three months ended June 30, 2005 was much lower than the comparable prior-year period which
included certain nonrecurring adjustments related to the acquisition of Noveon International. The
tax rate for the six months ended June 30, 2005 was lower than the comparable 2004 rate mainly
because of tax impacts discrete to the second quarter of 2005, including the favorable impact of a
deferred tax revaluation resulting from changes in Ohio law enacted on June 30, 2005.
Primarily as a result of the above factors, our basic net income per share was $0.88 and $1.60 for
the three and six months ended June 30, 2005 as compared to $0.08 and $0.80 for the prior-year
periods, respectively. The Noveon International acquisition, including equity issuances and
transaction financing, was accretive to earnings per share by $0.05 and $0.10 per share in the
three and six months ended June 30, 2005. Restructuring charges recorded in the three and six
months ended June 30, 2005 reduced earnings by $0.06 and $0.12 per share, respectively. Earnings
in both the three and six months ended June 30, 2004 included a one-time write-off of IPR&D
projects from the Noveon International acquisition of $0.42 per share, a purchase adjustment
associated with the increased valuation of Noveon International-acquired inventory of $0.06 per
share, acquisition-related financing costs of $0.14 per share and a restructuring charge of $0.10
per share. In addition, net other income for the six months ended June 30, 2004 included a gain on
a foreign currency forward contract of $0.08 per share.
SEGMENT ANALYSIS
We primarily evaluate performance and allocate resources based on segment operating income, defined
as revenues less expenses identifiable to the product lines included within each segment, as well
as projected future returns. Segment operating income will reconcile to consolidated income before
tax by deducting corporate expenses and corporate other income (expense) that are not directly
attributable to the operating segments, the write-off of acquired IPR&D, restructuring charges and
net interest expense.
The break-out of consolidated revenues and segment operating income by segment was as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months |
|
Six Months |
|
|
|
Ended June 30, |
|
Ended June 30, |
|
|
|
2005 |
|
2004 |
|
2005 |
|
2004 |
Revenues: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Lubricant Additives |
|
|
58 |
% |
|
|
72 |
% |
|
|
56 |
% |
|
|
78 |
% |
Specialty Chemicals |
|
|
42 |
% |
|
|
28 |
% |
|
|
44 |
% |
|
|
22 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Segment Operating Income: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Lubricant Additives |
|
|
62 |
% |
|
|
86 |
% |
|
|
60 |
% |
|
|
89 |
% |
Specialty Chemicals |
|
|
38 |
% |
|
|
14 |
% |
|
|
40 |
% |
|
|
11 |
% |
-36-
Item 2. Managements Discussion and Analysis of Financial Condition and Results of Operations (continued)
The operating results by segment for the three and six months ended June 30, 2005 and 2004 were as
follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Periods Ended |
|
|
|
|
|
|
|
|
|
|
Excluding |
|
|
|
June 30, |
|
|
|
|
|
|
|
|
|
|
Acquisitions |
|
(in millions of dollars) |
|
2005 |
|
|
2004 |
|
|
$ Change |
|
|
% Change |
|
$ Change |
|
|
% Change |
Revenues |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Lubricant Additives |
|
$ |
619.9 |
|
|
$ |
522.8 |
|
|
$ |
97.1 |
|
|
|
19 |
% |
|
$ |
97.1 |
|
|
|
19 |
% |
Specialty Chemicals |
|
|
446.7 |
|
|
|
198.7 |
|
|
|
248.0 |
|
|
|
125 |
% |
|
|
12.6 |
|
|
|
6 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
1,066.6 |
|
|
$ |
721.5 |
|
|
$ |
345.1 |
|
|
|
48 |
% |
|
$ |
109.7 |
|
|
|
15 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Six Months: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Lubricant Additives |
|
$ |
1,144.5 |
|
|
$ |
1,014.7 |
|
|
$ |
129.8 |
|
|
|
13 |
% |
|
$ |
129.8 |
|
|
|
13 |
% |
Specialty Chemicals |
|
|
893.2 |
|
|
|
285.5 |
|
|
|
607.7 |
|
|
|
213 |
% |
|
|
16.5 |
|
|
|
6 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
2,037.7 |
|
|
$ |
1,300.2 |
|
|
$ |
737.5 |
|
|
|
57 |
% |
|
$ |
146.3 |
|
|
|
11 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross Profit |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Lubricant Additives |
|
$ |
152.0 |
|
|
$ |
143.5 |
|
|
$ |
8.5 |
|
|
|
6 |
% |
|
$ |
8.5 |
|
|
|
6 |
% |
Specialty Chemicals |
|
|
118.9 |
|
|
|
47.1 |
|
|
|
71.8 |
|
|
|
152 |
% |
|
|
7.8 |
|
|
|
17 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
270.9 |
|
|
$ |
190.6 |
|
|
$ |
80.3 |
|
|
|
42 |
% |
|
$ |
16.3 |
|
|
|
9 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Six Months: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Lubricant Additives |
|
$ |
285.4 |
|
|
$ |
272.3 |
|
|
$ |
13.1 |
|
|
|
5 |
% |
|
$ |
13.1 |
|
|
|
5 |
% |
Specialty Chemicals |
|
|
238.5 |
|
|
|
69.9 |
|
|
|
168.6 |
|
|
|
241 |
% |
|
|
6.2 |
|
|
|
9 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
523.9 |
|
|
$ |
342.2 |
|
|
$ |
181.7 |
|
|
|
53 |
% |
|
$ |
19.3 |
|
|
|
6 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Segment
Operating Income |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Lubricant Additives |
|
$ |
85.2 |
|
|
$ |
72.8 |
|
|
$ |
12.4 |
|
|
|
17 |
% |
|
$ |
12.4 |
|
|
|
17 |
% |
Specialty Chemicals |
|
|
51.4 |
|
|
|
11.4 |
|
|
|
40.0 |
|
|
|
351 |
% |
|
|
11.3 |
|
|
|
99 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
136.6 |
|
|
$ |
84.2 |
|
|
$ |
52.4 |
|
|
|
62 |
% |
|
$ |
23.7 |
|
|
|
28 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Six Months: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Lubricant Additives |
|
$ |
154.0 |
|
|
$ |
135.5 |
|
|
$ |
18.5 |
|
|
|
14 |
% |
|
$ |
18.5 |
|
|
|
14 |
% |
Specialty Chemicals |
|
|
103.0 |
|
|
|
16.4 |
|
|
|
86.6 |
|
|
|
528 |
% |
|
|
13.6 |
|
|
|
83 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
257.0 |
|
|
$ |
151.9 |
|
|
$ |
105.1 |
|
|
|
69 |
% |
|
$ |
32.1 |
|
|
|
21 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
-37-
Item 2. Managements Discussion and Analysis of Financial Condition and Results of Operations (continued)
Lubricant Additives Segment
Revenues increased 19% for the three months ended June 30, 2005 compared to the same period in
2004, primarily due to a 14% improvement in the combination of price and product mix, 2% favorable
currency impact and 2% favorable volume. Revenues increased 13% for the six months ended June 30,
2005 compared to the same period in 2004, primarily due to a 12% improvement in the combination of
price and product mix and 2% favorable currency impact, partially offset by 2% unfavorable volume.
In addition, higher revenues from our equipment companies contributed 1% toward the favorable
increase in revenues in both the three and six months ended June 30, 2005 compared to the prior
year periods.
Shipment volume patterns vary in different geographic zones. The following table shows our
shipment volume by geographic zone for the three and six months ended June 30, 2005.
|
|
|
|
|
|
|
|
|
|
|
2nd Quarter |
|
Year-to-Date |
|
|
2005 |
|
2005 |
|
|
Volume |
|
Volume |
|
|
|
|
|
|
|
|
|
North America |
|
|
38 |
% |
|
|
39 |
% |
Europe |
|
|
30 |
% |
|
|
31 |
% |
Asia-Pacific / Middle East |
|
|
26 |
% |
|
|
25 |
% |
Latin America |
|
|
6 |
% |
|
|
5 |
% |
|
|
|
|
|
Total |
|
|
100 |
% |
|
|
100 |
% |
|
|
|
|
|
The following table shows the changes in our shipment volume by geographic zone for the three and
six months ended June 30, 2005 compared with the corresponding periods in 2004.
|
|
|
|
|
|
|
|
|
|
|
2nd Quarter |
|
Year-to-Date |
|
|
2005 vs. 2004 |
|
2005 vs. 2004 |
|
|
% Change |
|
% Change |
|
|
|
|
|
|
|
|
|
North America |
|
|
(4 |
%) |
|
|
(9 |
%) |
Europe |
|
|
2 |
% |
|
|
3 |
% |
Asia-Pacific / Middle East |
|
|
14 |
% |
|
|
6 |
% |
Latin America |
|
|
(2 |
%) |
|
|
(9 |
%) |
Total |
|
|
2 |
% |
|
|
(2 |
%) |
Although volume increased 2% for the three months ended June 30, 2005 compared to the same period
in 2004, the increase was tempered by the final piece of lost business of a major international
customer in the second half of 2004 and the impact on shipment volumes of the higher concentration
associated with the new passenger car technical standard GF-4 as compared to GF-3. Excluding these
items, volume increased 8% in total and 9% in North America for the three months ended June 30,
2005, and increased 4% in total and 4% in North America for the six months ended June 30, 2005
compared to the same periods in 2004. Volume for the three months ended June 30, 2005 also was
affected by some customer inventory build-up and the rebound of economic demand for passenger car
motor oil products. Higher shipment volume in Europe for both periods primarily was due to
increases in our engine additives product line due to market share gains. The shipment volume
increase in Asia-Pacific for both periods primarily was
-38-
Item 2. Managements Discussion and Analysis of Financial Condition and Results of Operations (continued)
due to timing of order patterns. In addition, for the three months ended June 30, 3005, the
Asia-Pacific region benefited from some temporary business gains due to one of our competitors
supply difficulties. The decrease in Latin America for both periods primarily was due to some lost
business within our engine additives product line and a shift in finished fluid blending volume
from Latin America to North America.
The Lubricant Additives segment implemented a price increase beginning in April 2005 for all
products sourced from North America, Asia-Pacific and Latin America and in May 2005 for products
sourced from Europe. In addition, we announced a second price increase that was effective in July
2005 for products sourced from North America, and that will be effective in August 2005 for
products sourced from Asia-Pacific and Latin America and in September 2005 for shipments made to
all customers in Europe and Africa. These price increases were in response to continued raw
material cost increases in 2005.
Segment gross profit includes material cost and all manufacturing expenses. Segment gross profit
increased 6% for the three months ended June 30, 2005 and 5% for the six months ended June 30,
2005, compared with the same periods in 2004. The increase for both periods primarily was due to
the cumulative impact of the selling price increases, partially offset by higher average raw
material cost and higher manufacturing costs. In the three and six months ended June 30, 2005,
average material cost increased 23% and 22%, respectively, compared to the same periods in 2004.
Manufacturing costs increased 14% and 4%, respectively, for the three and six months ended June 30,
2005 compared to the prior periods in 2004, primarily due to unfavorable currency and higher
maintenance and utilities expenses. Higher shipment volume in the second quarter of 2005 also
contributed to the increase in manufacturing costs flowing through the income statement for the
three months ended June 30, 2005 compared to the same period in 2004. In addition, higher gross
profit from our equipment companies contributed 1% of the increase in segment gross profit for both
the three and six months ended June 30, 2005, compared to the same periods in 2004.
The gross profit percentage for the segment was 24.5% and 25.0% for the three and six months ended
June 30, 2005, respectively, compared with 27.5% and 26.9%, in the prior year periods. The
decrease primarily was due to raw material costs rising proportionally faster than selling prices
along with increased manufacturing costs.
STAR expenses for the three and six months ended June 30, 2005 decreased $4.3 million (6%) and $4.4
million (3%), respectively, compared to the same periods in 2004. The decrease for both periods
primarily was due to lower technical expenses of $2.2 million and $4.2 million, respectively, as
well as lower variable pay expense in the three-month comparative period. The decrease in
technical expenses in both periods primarily was due to savings associated with the June 2004
workforce reduction and lower outside technical expenses. We anticipate testing expenses will
accelerate in the second half of 2005 as compared to the first half.
Segment operating income increased 17% and 14% for the three and six months ended June 30, 2005,
respectively, compared with the same periods in 2004 due to the factors discussed above.
-39-
Item 2. Managements Discussion and Analysis of Financial Condition and Results of Operations (continued)
Specialty Chemicals Segment
Revenues for the Specialty Chemicals segment increased 125% in the three months ended June 30, 2005
and 213% in the six months ended June 30, 2005 compared with the same periods in the prior year
primarily due to the 2004 acquisition of Noveon International for the three-month period and the
2004 acquisitions of Noveon International and the hyperdispersants business for the six-month
period. Excluding acquisitions, segment revenues increased 6% in the three months ended June 30,
2005 compared with the same period in the prior year due to a 12% improvement in the combination of
price and product mix and a 1% favorable currency impact partially offset by a 7% decrease in
shipment volume. Excluding acquisitions, segment revenues increased 6% in the six months ended
June 30, 2005 compared with the same period in the prior year due to an 11% improvement in the
combination of price and product mix and a 1% favorable currency impact partially offset by a 6%
decrease in shipment volume. The higher-priced product mix for both the three- and six-month
periods primarily occurred in our consumer specialties product line and to a lesser extent in our
performance coatings product line.
Shipment volume patterns vary in different geographic zones. The following table shows our
shipment volume by geographic zone for the three and six months ended June 30, 2005.
|
|
|
|
|
|
|
|
|
|
|
2nd Quarter |
|
Year-to-Date |
|
|
2005 |
|
2005 |
|
|
Volume |
|
Volume |
|
|
|
|
|
|
|
|
|
North America |
|
|
70 |
% |
|
|
71 |
% |
Europe |
|
|
16 |
% |
|
|
16 |
% |
Asia-Pacific / Middle East |
|
|
10 |
% |
|
|
9 |
% |
Latin America |
|
|
4 |
% |
|
|
4 |
% |
|
|
|
|
|
Total |
|
|
100 |
% |
|
|
100 |
% |
|
|
|
|
|
The following table shows the changes in our shipment volume by geographic zone as compared with
the corresponding periods in 2004.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Excluding |
|
|
|
|
|
|
Acquisitions |
|
|
2005 vs. 2004 |
|
2005 vs. 2004 |
|
|
% Change |
|
% Change |
Second Quarter: |
|
|
|
|
|
|
|
|
North America |
|
|
74 |
% |
|
|
(12 |
%) |
Europe |
|
|
92 |
% |
|
|
13 |
% |
Asia-Pacific / Middle East |
|
|
150 |
% |
|
|
3 |
% |
Latin America |
|
|
83 |
% |
|
|
(2 |
%) |
Total |
|
|
82 |
% |
|
|
(7 |
%) |
|
|
|
|
|
|
|
|
|
Year-to-Date: |
|
|
|
|
|
|
|
|
North America |
|
|
128 |
% |
|
|
(10 |
%) |
Europe |
|
|
152 |
% |
|
|
11 |
% |
Asia-Pacific / Middle East |
|
|
265 |
% |
|
|
|
|
Latin America |
|
|
138 |
% |
|
|
(1 |
%) |
Total |
|
|
140 |
% |
|
|
(6 |
%) |
-40-
Item 2. Managements Discussion and Analysis of Financial Condition and Results of Operations (continued)
Excluding acquisitions, the shipment volume decrease in North America for the three and six months
ended June 30, 2005 occurred in all product lines. The decrease in our consumer specialties and
performance coatings product line primarily was due to exiting certain low margin business and some
market share loss due to competitive activity in response to our price increases. The decrease in
specialty materials, following a very strong first quarter, primarily was due to reduced customer
buying in part because of the merger of two large customers. The increase in Europe for both
periods primarily was due to new business gained in our consumer specialties business. The increase
in Asia-Pacific / Middle East for the three months ended June 30, 2005 was due to higher shipment
volumes across all of our product lines resulting from higher demand and order pattern as we
rebounded from a slow first quarter in this region.
Segment gross profit increased $71.8 million, or 152% (increased $7.8 million, or 17%, excluding
acquisitions), for the three months ended June 30, 2005 compared with the same period in 2004 and
increased $168.6 million, or 241% (increased $6.2 million, or 9%, excluding acquisitions) for the
six months ended June 30, 2005 compared to the same period in 2004. Excluding acquisitions, the
increase in segment gross profit for the three-month and six-month periods primarily was due to
higher revenues due to an improvement in the combination of price and product mix partially offset
by higher raw material costs and slightly higher manufacturing expenses. Average raw material cost
increased 11% for the three-month and six-month periods compared with the same periods in 2004.
Second quarter 2004 material cost also includes the impact of $4.9 million of inventory step-up
amortization from acquisition accounting. Excluding the impact of the step-up in 2004, average raw
material cost increased 17% for the three-month and 15% for the six-month periods ended June 30,
2005 compared to the same periods in 2004. Excluding acquisitions, manufacturing expenses increased 2% and 7% for the
three and six months ended June 30, 2005, respectively, primarily due to higher spending partially
offset by a favorable depreciation adjustment of $1.1 million in the three-month period related to
a purchase accounting adjustment.
The gross profit percentage for this segment was 26.6% and 26.7% for the three and six months ended
June 30, 2005, respectively, compared with 23.7% and 24.5% in
the prior-year periods. Excluding acquisitions, the gross profit percentage was 26.0% and 25.2% for the
three and six months ended June 30, 2005, respectively. Excluding the impact of the inventory
step-up amortization, the gross profit percentage for both periods in 2004 was 26.2%. The decrease
in the gross profit percentage for both periods compared to the same periods in 2004, excluding the
impact of acquisitions and the inventory step-up in 2004, was due to raw material costs rising
proportionally faster than selling prices along with increased manufacturing costs.
STAR expenses increased $30.4 million, or 92% (decreased $2.8 million, or 8%, excluding
acquisitions), for the three months ended June 30, 2005 compared with the same period in 2004 and
increased $75.7 million, or 151% (decreased $7.1 million, or 14% excluding acquisitions) for the
six months ended June 30, 2005 compared with the same period in 2004. Excluding acquisitions, the
decrease in STAR expenses primarily was due to the consolidation of some segment administrative
functions into corporate functions and reduced spending as a result of the integration of general
and administrative functions.
Segment operating income increased $40.0 million and $86.6 million in the three and six months
ended June 30, 2005 (increased $11.3 million and $13.6 million, excluding acquisitions),
respectively, compared with the same periods in 2004. Excluding acquisitions, the increase in
segment operating profit primarily was due to the increase in segment gross profit and the decrease
in STAR expenses.
-41-
Item 2. Managements Discussion and Analysis of Financial Condition and Results of Operations (continued)
PRO FORMA ANALYSIS
The following table presents major components of and information derived from the pro forma
consolidated statements of income and pro forma consolidated statements of cash flows for the three
and six months ended June 30, 2004. The major components of the pro forma consolidated statements
of income and pro forma consolidated statements of cash flows reflect the effect of the acquisition
of Noveon International on June 3, 2004 as if the acquisition occurred as of the beginning of each
of the pro forma periods presented below in the table. We believe that this data provides the
financial statement reader with information that is useful in understanding the impact of the
acquisition of Noveon International on our results of operations and cash flows.
The components of and information derived from the pro forma consolidated statements of income and
the pro forma consolidated statements of cash flows for the three and six months ended June 30,
2004 are derived from our unaudited consolidated financial statements for the three and six months
ended June 30, 2004 and the unaudited consolidated financial statements of Noveon International for
the three and six months ended June 30, 2004.
Our consolidated balance sheet as of June 30, 2005 reflects the acquisition of Noveon International
under the purchase method of accounting. The allocation of the purchase price was complete as of
June 30, 2005.
The pro forma data gives effect to actual operating results of Noveon International prior to the
acquisition. Adjustments to cost of sales for the inventory step-up charge, fixed asset
depreciation, intangible asset amortization, the write-off of acquired IPR&D, interest expense and
income taxes related to the acquisition are reflected in the pro forma data. The entire inventory
step-up charge is attributable to the Specialty Chemicals segment. In addition, we assumed that
the bridge loan obtained at the time of the transaction closing was not replaced with the permanent
long-term financing of both debt and equity until the end of the fourth month in the period
presented. This pro forma data is consistent with the pro forma data that is disclosed in Note 3
to the unaudited consolidated financial statements for the three and six months ended June 30,
2004. These pro forma amounts do not purport to be indicative of the results that actually would
have been obtained if the acquisition had occurred as of the beginning of the periods presented or
that may be obtained in the future.
-42-
Item 2. Managements Discussion and Analysis of Financial Condition and Results of Operations (continued)
The following table summarizes the comparative pro forma data:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
Six Months Ended |
|
|
|
June 30, |
|
|
June 30, |
|
(in millions of dollars) |
|
Actual 2005 |
|
|
Pro Forma 2004 |
|
|
Actual 2005 |
|
|
Pro Forma 2004 |
|
Consolidated Data |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total revenues |
|
$ |
1,066.6 |
|
|
$ |
939.0 |
|
|
$ |
2,037.7 |
|
|
$ |
1,837.8 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross profit |
|
$ |
270.9 |
|
|
$ |
253.6 |
|
|
$ |
523.9 |
|
|
$ |
496.0 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income before income taxes |
|
$ |
90.6 |
|
|
$ |
23.4 |
|
|
$ |
164.6 |
|
|
$ |
93.3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income |
|
$ |
60.1 |
|
|
$ |
15.0 |
|
|
$ |
108.6 |
|
|
$ |
59.7 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Depreciation expense |
|
$ |
38.4 |
|
|
$ |
40.3 |
|
|
$ |
79.0 |
|
|
$ |
81.9 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Amortization of intangible assets |
|
$ |
6.1 |
|
|
$ |
6.3 |
|
|
$ |
12.7 |
|
|
$ |
12.3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Capital expenditures |
|
$ |
28.9 |
|
|
$ |
33.6 |
|
|
$ |
58.6 |
|
|
$ |
65.3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Segment Data |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Lubricant Additives Segment |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total revenues |
|
$ |
619.9 |
|
|
$ |
522.8 |
|
|
$ |
1,144.5 |
|
|
$ |
1,014.7 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross profit |
|
$ |
152.0 |
|
|
$ |
143.5 |
|
|
$ |
285.4 |
|
|
$ |
272.3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Segment operating income |
|
$ |
85.2 |
|
|
$ |
72.8 |
|
|
$ |
154.0 |
|
|
$ |
135.5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Depreciation expense |
|
$ |
19.7 |
|
|
$ |
21.0 |
|
|
$ |
41.2 |
|
|
$ |
42.9 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Amortization of intangible assets |
|
$ |
0.8 |
|
|
$ |
0.8 |
|
|
$ |
1.5 |
|
|
$ |
1.5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Capital expenditures |
|
$ |
17.4 |
|
|
$ |
17.3 |
|
|
$ |
33.0 |
|
|
$ |
35.6 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Specialty Chemicals Segment |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total revenues |
|
$ |
446.7 |
|
|
$ |
416.2 |
|
|
$ |
893.2 |
|
|
$ |
823.1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross profit |
|
$ |
118.9 |
|
|
$ |
110.1 |
|
|
$ |
238.5 |
|
|
$ |
223.7 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Segment operating income |
|
$ |
51.4 |
|
|
$ |
38.2 |
|
|
$ |
103.0 |
|
|
$ |
81.8 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Depreciation expense |
|
$ |
18.5 |
|
|
$ |
19.0 |
|
|
$ |
37.4 |
|
|
$ |
38.4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Amortization of intangible assets |
|
$ |
5.3 |
|
|
$ |
5.5 |
|
|
$ |
11.2 |
|
|
$ |
10.8 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Capital expenditures |
|
$ |
11.3 |
|
|
$ |
16.3 |
|
|
$ |
25.4 |
|
|
$ |
29.7 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unallocated corporate depreciation
expense |
|
$ |
0.2 |
|
|
$ |
0.3 |
|
|
$ |
0.4 |
|
|
$ |
0.6 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unallocated corporate capital
expenditures |
|
$ |
0.2 |
|
|
$ |
|
|
|
$ |
0.2 |
|
|
$ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
-43-
Item 2. Managements Discussion and Analysis of Financial Condition and Results of Operations (continued)
Comparative pro forma data (continued):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended June 30, |
|
|
Six Months Ended June 30, |
|
(in millions of dollars) |
|
Actual 2005 |
|
|
Pro Forma 2004 |
|
|
Actual 2005 |
|
|
Pro Forma 2004 |
|
Reconciliation of Segment Operating |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income to Income before Income
Taxes |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Segment operating income: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Lubricant Additives Segment |
|
$ |
85.2 |
|
|
$ |
72.8 |
|
|
$ |
154.0 |
|
|
$ |
135.5 |
|
Specialty Chemicals Segment |
|
|
51.4 |
|
|
|
38.2 |
|
|
|
103.0 |
|
|
|
81.8 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total segment operating income |
|
|
136.6 |
|
|
|
111.0 |
|
|
|
257.0 |
|
|
|
217.3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Corporate expenses |
|
|
(15.8 |
) |
|
|
(12.3 |
) |
|
|
(30.8 |
) |
|
|
(21.6 |
) |
Corporate other income (expense) |
|
|
0.1 |
|
|
|
(2.0 |
) |
|
|
(0.7 |
) |
|
|
1.8 |
|
Write-off of acquired IPR&D |
|
|
|
|
|
|
(34.0 |
) |
|
|
|
|
|
|
(34.0 |
) |
Restructuring charges |
|
|
(5.4 |
) |
|
|
(8.5 |
) |
|
|
(11.5 |
) |
|
|
(11.3 |
) |
Interest expense - net |
|
|
(24.9 |
) |
|
|
(30.8 |
) |
|
|
(49.4 |
) |
|
|
(58.9 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Income before income taxes |
|
$ |
90.6 |
|
|
$ |
23.4 |
|
|
$ |
164.6 |
|
|
$ |
93.3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
WORKING CAPITAL, LIQUIDITY AND CAPITAL RESOURCES
The following table summarizes the major components of cash flow:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Six Months Ended June 30, |
|
|
|
|
(in millions of dollars) |
|
2005 |
|
|
2004 |
|
|
$ Change |
|
Cash provided by (used for): |
|
|
|
|
|
|
|
|
|
|
|
|
Operating activities |
|
$ |
140.6 |
|
|
$ |
96.2 |
|
|
$ |
44.4 |
|
Investing activities |
|
|
(55.4 |
) |
|
|
(1,002.9 |
) |
|
|
947.5 |
|
Financing activities |
|
|
(126.3 |
) |
|
|
868.9 |
|
|
|
(995.2 |
) |
Effect of exchange-rate changes on cash |
|
|
(15.8 |
) |
|
|
6.4 |
|
|
|
(22.2 |
) |
|
|
|
|
|
|
|
|
|
|
Net decrease in cash and
short-term investments |
|
$ |
(56.9 |
) |
|
$ |
(31.4 |
) |
|
$ |
(25.5 |
) |
|
|
|
|
|
|
|
|
|
|
-44-
Item 2. Managements Discussion and Analysis of Financial Condition and Results of Operations (continued)
Operating Activities
The increase in cash provided by operating activities in the six months ended June 30, 2005
compared with the prior year primarily was due to an increase in earnings after adjusting for
non-cash items. The increase in earnings partially was offset by an $88.0 million increase in
receivables since December 31, 2004. This compares to a $77.0 million increase in the prior-year
comparable period. The year-end seasonality in sales and collections for the holidays is a
significant contributing factor related to the change in the receivables balance since December 31,
2004.
We manage our levels of inventories and accounts receivable on the basis of average days sales in
inventory and average days sales in receivables. Our target for accounts receivable is established
taking into consideration the weighted average of our various terms of trade for each segment. Our
target for days sales in inventory for each segment is established with the goal of minimizing our
investment in inventories while at the same time ensuring adequate supply for our customers.
Improvement in both the timing of cash collections and inventory turns helped mitigate the increase
in working capital due to higher average selling price and higher inventory costs. We continue to
expect incremental improvement in the days sales metrics as compared to 2004 by the end of the
year.
Investing Activities
Our capital expenditures for the six months ended June 30, 2005 were $58.6 million, as compared
with $42.2 million for the same period in 2004. In 2005, we estimate annual capital expenditures
will be approximately $155.0 million, including $5.0 million of capital expenditures related to the
transfer of production from the three manufacturing facilities scheduled for closure to other
facilities.
The net decrease in cash used to fund acquisitions in the first half of 2005 as compared to the
prior year relates to the acquisitions of the hyperdispersants business of Avecia in January 2004
and Noveon International in June 2004.
Financing Activities
The decrease in cash provided by financing activities of $995.2 million in the six months ended
June 30, 2005 primarily was due to the $125.0 million in term-loan payments made in the second
quarter of 2005 as compared to an increase in borrowings of $1,797.0 million under our then
$2,450.0 million 364-day bridge facility in June 2004, the proceeds of which were used to fund the
Noveon International acquisition and repay related assumed debt of $1,103.1 million.
Capitalization, Liquidity and Credit Facilities
At June 30, 2005, our total debt outstanding of $1,840.8 million consisted of 58% fixed-rate debt
and 42% variable-rate debt, including $400.0 million of fixed-rate debt that effectively has been
swapped to variable-rate debt. Our weighted-average borrowing rate as of June 30, 2005 was
approximately 5.3%.
Our net debt to capitalization ratio at June 30, 2005 was 50%. Net debt is the total of short-term
and long-term debt, reduced by cash and short-term investments excluding original issue discounts
and unrealized gains and losses on derivative instruments designated as fair-value hedges of
fixed-rate debt. Capitalization is shareholders equity plus net debt. Total debt as a percent of
capitalization was 54% at June 30, 2005.
Our ratio of current assets to current liabilities increased from 2.4 at December 31, 2004 to 2.6
at June 30, 2005, primarily due to working capital increases associated with higher sales and the
timing of collections and disbursements. The increase in accounts receivable of $58.3 million
since December 31, 2004 primarily was driven by higher sales in the second quarter of 2005 as
compared to the fourth quarter of 2004 as well as seasonality. The decrease in accounts payable,
accrued expenses and other current liabilities of $46.3 million since December 31, 2004 primarily
was due to
-45-
Item 2. Managements Discussion and Analysis of Financial Condition and Results of Operations (continued)
disbursement timing associated with the payment of items such as compensation and benefits
accruals, dividends, rebates, insurance and taxes.
At June 30, 2005, we had a $500.0 million revolving credit facility that matures in August 2009,
which allows us to borrow at variable rates based upon the U.S. prime rate or LIBOR plus a
specified credit spread. As of June 30, 2005, we had no outstanding borrowings under this
agreement.
On March 29, 2005, we amended and restated our five-year unsecured bank credit agreement to reduce
the credit spread paid on the outstanding $500.0 million term loans. Based on our current
unsecured senior debt ratings from Standard and Poors and Moodys Investors Services, the credit
spread on the term loans was reduced by 50 basis points. No other terms or conditions of the
agreement were modified.
In the three months ended June 30, 2005, the company repaid $125.0 million against the bank term
loan. The balance outstanding at June 30, 2005 under the term-loan arrangement was $375.0 million.
In July 2005, the company repaid an additional $25.0 million against the bank term loan to reduce
the remaining outstanding balance to $350.0 million.
Contractual Cash Obligations
Our contractual cash obligations as of December 31, 2004 are contained on page 21 of our 2004
Annual Report to shareholders. We do not believe there have been any significant changes since
December 31, 2004 in that information.
Our debt level will require us to dedicate a significant portion of our cash flow to make interest
and principal payments, thereby reducing the availability of our cash flow for acquisitions or
other purposes. Nevertheless, we believe our future operating cash flows will be sufficient to
cover our debt repayments, capital expenditures, dividends and other obligations and that we have
untapped borrowing capacity that can provide us with additional financial resources. We currently
have a shelf registration statement filed with the Securities and Exchange Commission (SEC) under
which $359.8 million of debt securities, preferred shares or common shares may be issued. In
addition, as of June 30, 2005, we maintained cash and short-term investment balances of $279.0
million and had $500.0 million available under our revolving credit facility.
NEW ACCOUNTING STANDARDS
In June 2005, the Financial Accounting Standards Board (FASB) issued SFAS No. 154, Accounting
Changes and Error Corrections. This standard establishes new standards on accounting for changes
in accounting principles. Pursuant to the new rules, all such changes must be accounted for by
retrospective application to the financial statements of prior periods unless it is impracticable
to do so. SFAS No. 154 completely replaces Accounting Principles Board (APB) Opinion No. 20 and
SFAS No. 3, though it carries forward the guidance in those pronouncements with respect to
accounting for changes in estimates, changes in the reporting entity, and the correction of errors.
We do not believe the adoption of this standard will have a material impact on our financial
position, results of operations or cash flows.
In March 2005, the FASB issued Interpretation (FIN) No. 47, Accounting for Conditional
Asset-Retirement Obligations. This standard codifies SFAS No. 143, Asset-Retirement
Obligations, and states that companies must recognize a liability for the fair value of a legal
obligation to perform asset-retirement obligations that are conditional on a future event if the
amount can be reasonably estimated. Specifically, FIN No. 47 provides additional guidance on
whether the fair value is reasonably estimable. FIN No. 47 is effective for us starting January 1,
2006. We do not believe the adoption of this standard will have a material impact on our financial
position, results of operations or cash flows.
-46-
Item 2. Managements Discussion and Analysis of Financial Condition and Results of Operations (continued)
In December 2004, the FASB issued SFAS No. 123(R), Share-Based Payment. This standard will
require compensation costs related to share-based payment transactions to be recognized in the
financial statements. With limited exceptions, the amount of compensation cost will be measured
based on the grant-date fair value of the equity or liability instruments issued. In addition,
liability awards will be remeasured each reporting period. Compensation cost will be recognized
over the period that an employee provides service in exchange for the award. This standard
replaces SFAS No. 123 and supersedes APB Opinion No. 25, Accounting for Stock Issued to
Employees, and applies to all awards granted, modified, repurchased or cancelled after July 1,
2005. In April 2005, the SEC amended the compliance date of SFAS No. 123(R) through an amendment
of Regulation S-X. The new effective date for us is January 1, 2006. We are currently evaluating
the provisions of this standard to determine the impact on our consolidated financial statements.
It is, however, expected to reduce consolidated net income.
In December 2004, the FASB issued SFAS No. 153, Exchanges of Nonmonetary Assets. This standard
amended APB Opinion No. 29, Accounting for Nonmonetary Transactions, to eliminate the exception
from fair value measurement for nonmonetary exchanges of similar productive assets. This standard
replaces this exception with a general exception from fair value measurement for exchanges of
nonmonetary assets that do not have commercial substance. A nonmonetary exchange has commercial
substance if the future cash flows of the entity are expected to change significantly as a result
of the exchange. This statement is effective for all nonmonetary asset exchanges we complete
starting January 1, 2006. We do not believe the adoption of this standard will have a material
impact on our financial position, results of operations or cash flows.
In November 2004, the FASB issued SFAS No. 151, Inventory Costs, to clarify the accounting for
abnormal amounts of idle facility expense, freight, handling costs and wasted material. This
standard requires that such items be recognized as current-period charges. The standard also
establishes the concept of normal capacity and requires the allocation of fixed production
overhead to inventory based on the normal capacity of the production facilities. Any unallocated
overhead must be recognized as an expense in the period incurred. This standard is effective for
inventory costs incurred starting January 1, 2006. We do not believe the adoption of this standard
will have a material impact on our financial position, results of operations or cash flows.
-47-
Item 2. Managements Discussion and Analysis of Financial Condition and Results of Operations (continued)
CAUTIONARY STATEMENTS FOR SAFE HARBOR PURPOSES
This Managements Discussion and Analysis of Financial Condition and Results of Operations contains
forward-looking statements within the meaning of the federal securities laws. As a general matter,
forward-looking statements are those focused upon future plans, objectives or performance as
opposed to historical items and include statements of anticipated events or trends and expectations
and beliefs relating to matters not historical in nature. Forward-looking statements are subject
to uncertainties and factors relating to our operations and business environment, all of which are
difficult to predict and many of which are beyond our control. These uncertainties and factors
could cause our actual results to differ materially from those matters expressed in or implied by
any forward-looking statements, although we believe our expectations reflected in those
forward-looking statements are based upon reasonable assumptions. For this purpose, any statements
contained herein that are not statements of historical fact should be deemed to be forward-looking
statements.
We believe that the following factors, among others, could affect our future performance and cause
our actual results to differ materially from those expressed or implied by forward-looking
statements made in this quarterly report:
|
|
the cost, availability and quality of raw materials, including petroleum-based products; |
|
|
|
our ability to increase the prices of our products in a competitive environment; |
|
|
|
the effect of required principal and interest payments on our ability to fund capital expenditures and acquisitions and
to meet operating needs; |
|
|
|
the overall global economic environment and the overall demand for our products on a worldwide basis; |
|
|
|
technology developments that affect longer-term trends for our products; |
|
|
|
the extent to which we are successful in expanding our business in new and existing markets; |
|
|
|
our ability to identify, complete and integrate acquisitions for profitable growth and operating efficiencies,
especially our ability to integrate the acquisition of Noveon International; |
|
|
|
our success at continuing to develop proprietary technology to meet or exceed new industry performance standards and
individual customer expectations; |
|
|
|
our ability to continue to reduce complexities and conversion costs and modify our cost structure to maintain and
enhance our competitiveness; |
|
|
|
our success in retaining and growing the business that we have with our largest customers; |
|
|
|
the cost and availability of energy, including natural gas and electricity; |
|
|
|
the effect of interest rate fluctuations on our interest expense; |
|
|
|
the effects of fluctuations in currency exchange rates upon our reported results from international operations,
together with non-currency risks of investing in and conducting significant operations in foreign countries, including
those relating to political, social, economic and regulatory factors; |
|
|
|
the extent to which we achieve market acceptance of our commercial development programs; |
|
|
|
significant changes in government regulations affecting environmental compliance; |
|
|
|
the ability to identify, understand and manage risks inherent in new markets in which we choose to expand; and |
|
|
|
our ability to maintain operating continuity for those businesses identified as divestiture candidates. |
-48-
Item 3. Quantitative and Qualitative Disclosures About Market Risk
We operate manufacturing and blending facilities, laboratories and offices around the world and
utilize fixed and variable rate debt to finance our global operations. As a result, we are subject
to business risks inherent in non-U.S. activities, including political and economic uncertainties,
import and export limitations, and market risks related to changes in interest rates and foreign
currency exchange rates. We believe the political and economic risks related to our foreign
operations are mitigated due to the stability of the countries in which our largest foreign
operations are located.
In the normal course of business, we use derivative financial instruments including interest rate
and commodity hedges and forward foreign currency exchange contracts to manage our market risks.
Our objective in managing our exposure to changes in interest rates is to limit the impact of such
changes on our earnings and cash flow. Our objective in managing the exposure to changes in
foreign currency exchange rates is to reduce volatility on our earnings and cash flow associated
with such changes. Our principal currency exposures are the euro, the pound sterling, the Japanese
yen and certain Latin American currencies. Our objective in managing our exposure to changes in
commodity prices is to reduce the volatility on earnings of utility expense. We do not hold
derivatives for trading purposes.
We measure our market risk related to our holdings of financial instruments based on changes in
interest rates, foreign currency rates and commodity prices utilizing a sensitivity analysis. The
sensitivity analysis measures the potential loss in fair value, cash flow and earnings based on a
hypothetical 10% change (increase and decrease) in interest, currency exchange rates and commodity
prices. We use current market rates on our debt and derivative portfolios to perform the
sensitivity analysis. Certain items such as lease contracts, insurance contracts and obligations
for pension and other postretirement benefits are not included in the analysis.
Our primary interest rate exposures relate to our cash and short-term investments, fixed and
variable rate debt and interest rate swaps. The calculation of potential loss in fair value is
based on an immediate change in the net present values of our interest rate-sensitive exposures
resulting from a 10% change in interest rates. The potential loss in cash flow and income before
tax is based on the change in the net interest income/expense over a one-year period due to an
immediate 10% change in rates. A hypothetical 10% increase in interest rates would have had a
favorable impact and a hypothetical 10% decrease in interest rates would have had an unfavorable
impact on fair values of $44.5 million in 2005. In addition, a hypothetical 10% increase in
interest rates would have had an unfavorable impact and a hypothetical 10% decrease in interest
rates would have had a favorable impact on cash flows and income before tax of $2.6 million in 2005
on an annualized basis.
Our primary currency rate exposures are to foreign-denominated debt, intercompany loans, cash and
short-term investments and forward foreign currency exchange contracts. The calculation of
potential loss in fair value is based on an immediate change in the U.S. dollar equivalent balances
of our foreign currency exposures due to a 10% shift in exchange rates. The potential loss in cash
flow and income before tax is based on the change in cash flow and income before tax over a
one-year period resulting from an immediate 10% change in foreign currency exchange rates. A
hypothetical 10% increase in foreign currency exchange rates would have had a favorable impact and
a hypothetical 10% decrease in foreign currency exchange rates would have had an unfavorable impact
on fair values of $17.8 million, on annualized cash flows of $31.8 million and on annualized income
before tax of $10.4 million in 2005.
Our primary commodity hedge exposures relate to natural gas and electric utility expenses. The
calculation of potential loss in fair value is based on an immediate change in the U.S. dollar
equivalent balances of our commodity exposures due to a 10% shift in the underlying commodity
prices. The potential loss in cash flow and income before tax is based on the change in cash flow
and income before tax over a one-year period resulting from an immediate 10% change in commodity
prices. A hypothetical 10% increase in commodity prices would have had a favorable impact and a
hypothetical 10% decrease in commodity prices would have had an unfavorable impact on fair value of
$0.7 million and on annualized cash flows and income before tax of $0.7 million,
-49-
Item 4. Controls and Procedures
We evaluated, under the supervision and with the participation of our chief executive officer and
chief financial officer, the effectiveness of our disclosure controls and procedures (as defined in
Exchange Act Rule 13a-15(e)) as of June 30, 2005. Based on that evaluation, our chief executive
officer and chief financial officer concluded that, as of June 30, 2005, our disclosure controls
and procedures were effective in timely alerting them to material information relating to Lubrizol
and our consolidated subsidiaries required to be included in our periodic SEC filings. There were
no significant changes in our internal control over financial reporting that occurred during the
second quarter of 2005 that have materially affected, or are reasonably likely to materially
affect, our internal control over financial reporting.
PART II. OTHER INFORMATION
Item 1. Legal Proceedings
The company has voluntarily notified the U.S. Departments of Treasury and Commerce that an internal
review of certain export transactions within the personal care and pharmaceuticals business of the
specialty chemicals segment has indicated that some exports were made that were not in compliance
with current U.S. trade sanctions. The company has voluntarily committed to complete a thorough
review of all possibly non-complying transactions and to detail its findings in a subsequent report
expected to be made to the government in the third quarter of 2005. While the sales involved were
not substantial in relation to the company or the specialty chemicals segment, the company
considers legal compliance to be very important. At this time, the company cannot determine what
penalties or fines, if any, will be assessed against it, but applicable regulations provide that
the companys voluntary self-disclosure will be an important mitigating factor.
On May 13, 2005, the company was named in a suit alleging patent infringement. The suit is pending
in federal court in Norfolk, Virginia and pertains to some of the companys additives for automatic
transmission fluids sold by the Lubricant Additives segment. The company is contesting the suit
vigorously and neither the company nor its counsel believes that an unfavorable outcome is
probable.
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
|
(a) |
|
On April 8, 2005, we issued 941 common shares in a transaction exempt from
registration under the Securities Act of 1933 pursuant to Regulation S. We issued the
common shares under an employee benefit plan to one employee of a wholly owned United
Kingdom subsidiary of the company. |
|
|
|
|
On April 20, 2005, we issued 1,021 common shares in a private placement transaction
exempt from registration under the Securities Act of 1933 pursuant to Section 4(2) of
that Act. We issued the common shares to one former officer under a deferred
compensation plan for officers. |
|
|
|
|
On April 22, 2005, we issued 1,790 common shares in transactions exempt from
registration under the Securities Act of 1933 pursuant to Regulation S. We issued
the common shares under an employee benefit plan to three employees of a wholly owned
United Kingdom subsidiary of the company. |
|
|
|
|
On May 1, 2005, we issued 119 common shares in a private placement transaction exempt
from registration under the Securities Act of 1933 pursuant to Section 4(2) of that
Act. We issued the common shares to one former officer under a deferred compensation
plan for officers. |
|
|
|
|
On May 1, 2005, we issued 217 common shares in a private placement transaction exempt
from registration under the Securities Act of 1933 pursuant to Section 4(2) of that
Act. We issued the common shares to one former director under a deferred
compensation plan for directors. |
-50-
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds (continued)
|
|
|
On May 4, 2005, we issued 608 common shares in transactions exempt from registration
under the Securities Act of 1939 pursuant to Regulation S. We issued the common
shares under an employee benefit plan to two employees of a wholly owned United
Kingdom subsidiary of the company. |
|
|
|
|
On May 16, 2005, we issued 229 common shares in transactions exempt from registration
under the Securities Act of 1933 pursuant to Regulation S. We issued the common
shares under an employee benefit plan to two employees of a wholly owned United
Kingdom subsidiary of the company. |
|
|
|
|
On May 18, 2005, we issued 45,242 common shares in transactions exempt from
registration under the Securities Act of 1933 pursuant to Regulation S. We issued
the common shares under an employee benefit plan to 145 employees of a wholly owned
United Kingdom subsidiary of the company. |
|
|
|
|
On May 19, 2005, we issued 1,627 common shares in transactions exempt from
registration under the Securities Act of 1933 pursuant to Regulation S. We issued
the common shares under an employee benefit plan to four employees of a wholly owned
United Kingdom subsidiary of the company. |
|
|
|
|
On May 23, 2005, we issued 556 common shares in transactions exempt from registration
under the Securities Act of 1933 pursuant to Regulation S. We issued the common
shares under an employee benefit plan to four employees of a wholly owned United
Kingdom subsidiary of the company. |
|
|
|
|
On June 1, 2005, we issued 280 common shares in private placement transactions exempt
from registration under the Securities Act of 1933 pursuant to Section 4(2) of that
Act. We issued the common shares to two former officers under deferred compensation
plans for officers. |
|
|
|
|
On June 22, 2005, we issued 44 common shares in a transaction exempt from
registration under the Securities Act of 1939 pursuant to Regulation S. We issued
the common shares under an employee benefit plan to one employee of a wholly owned
United Kingdom subsidiary of the company. |
|
|
(c) |
|
The following table provides information regarding the companys purchases of
its common shares during the second quarter. |
-51-
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds (continued)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(d) Maximum Number |
|
|
|
|
|
|
|
|
|
|
|
(c) Total Number |
|
|
(or Approximate Dollar |
|
|
|
|
|
|
|
|
|
|
|
of Shares (or Units) |
|
|
Value) of Shares (or |
|
|
|
(a) Total Number of |
|
(b) Average Price |
|
|
Purchased as Part of |
|
|
Units) that May Yet |
|
|
|
Shares (or Units) |
|
Paid per Share |
|
|
Publicly Announced |
|
|
be Purchased Under the |
|
Period |
|
Purchased1 |
|
(or Unit) |
|
|
Plans or Programs |
|
|
Plans or Programs |
|
Month #1
(April 1, 2005 through
April 30, 2005) |
|
|
291 |
Shares |
|
$ |
40.64 |
|
|
|
N/A |
|
|
|
N/A |
|
Month #2
(May 1, 2005 through
May 31, 2005) |
|
|
30 |
Shares |
|
$ |
38.77 |
|
|
|
N/A |
|
|
|
N/A |
|
Month #3
(June 1, 2005 through
June 30, 2005) |
|
|
80 |
Shares |
|
$ |
39.37 |
|
|
|
N/A |
|
|
|
N/A |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
|
401 |
Shares |
|
|
|
|
|
|
|
|
|
|
|
|
1 This column represents common shares that were purchased by the
company pursuant to:
|
(a) |
|
our option plan, whereby participants exchange already
owned shares to us to pay for the exercise price of an option or whereby we
withhold shares upon the exercise of an option to pay the withholding taxes
on behalf of the employee. |
|
|
(b) |
|
our deferred compensation plans, whereby we withhold shares
upon a distribution to pay the withholding taxes on behalf of the employee. |
Item 4. Submission of Matters to a Vote of Security Holders
Our Annual Meeting of Shareholders was held on April 25, 2005. The following matters were voted on
by the shareholders:
|
a. |
|
Peggy Gordon Miller. The vote was 60,845,190 shares for and
1,832,176 shares to withhold authority. |
|
|
b. |
|
Dominic J. Pileggi. The vote was 61,580,891shares for and
1,096,475 shares to withhold authority. |
|
2. |
|
A proposal to adopt The Lubrizol Corporation 2005 Stock Incentive Plan. The
vote was 45,959,061 shares for; 8,290,650 shares against; and 1,586,655 abstaining. |
|
|
3. |
|
A proposal to confirm the appointment of Deloitte & Touche LLP as the
independent registered public accountant. The vote was 61,722,399 shares for; 840,288
shares against; and 64,678 shares abstaining. |
-52-
Item 6. Exhibits
|
31.1 |
|
Rule 13a-14(a) Certification of the Chief Executive Office, as created by Section
302 of the Sarbanes-Oxley Act of 2002. |
|
|
31.2 |
|
Rule 13a-14(a) Certification of the Chief Financial Officer, as created by
Section 302 of the Sarbanes-Oxley Act of 2002. |
|
|
32.1 |
|
Certification of the Chief Executive Officer and Chief Financial Officer of The
Lubrizol Corporation pursuant to 18 U.S.C. Section 1350, as created by Section 906 of
the Sarbanes-Oxley Act. |
Signatures
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused
this report to be signed on its behalf by the undersigned thereunto duly authorized.
THE LUBRIZOL CORPORATION
/s/ W. Scott Emerick
W. Scott Emerick
Chief Accounting Officer and Duly Authorized
Signatory of The Lubrizol Corporation
Date: August 4, 2005
-53-